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enzyme leakage (e.g LDH leakage 13% of total (350 um/min/mg 
protein), amino acid incorporation (lysine 0.56 pmol/mg protein, 
proline 0.3 6pmol/mg protein, histidine 0.19 pmol/mg protein) 
thymidine incorporation (0.18 pmol/mg protein), no change in ATP 
content (8 nmol/mg protein), and pentose phosphate pathway 
stimulation (ratio of Cl/C6-glucose was 1.56) to be viable for at 
least 4 hours.
The use of enzyme leakage as an indicator of toxicity was found 
to produce data that was difficult to interpret. This was 
partially due to the interaction of the compounds directly with 
the enzymes or the assay procedure (e.g streptomycin inhibited 
lactate dehydrogenase (LDH) activity and adriamycin (ADR) 
interfered with N-acetyl-beta-D-glucaminidase (NAG), beta-D- 
galactosidase (GALACT), glucaminidase (GLUC) and gamma- 
glutamyltranspeptidase (GGT) assays due to its intense red 
colour). The release of proteolytic enzymes from the glomerulus 
may have affected the activity of leaked enzymes.
Protein synthesis, measured by the de novo incorporation of amino 
acids, was a sensitive indicator of toxicity. The inhibition of 
proline was found to be particularly sensitive. For example, ADR 
inhibited proline incorporation by 50% at a concentration of 61 
uM, but a 50% increase in LDH leakage was only apparent when 
600uM of this anthracycline was present.
This sensitivity was selective, ADR and its analogue 
pharmarubicin both inhibited proline incorporation. In contrast 
the proximal tubular toxin hexachlorobutadiene-cystiene (HCBD- 
cystiene) had no effect on glomerular proline incorporation at 
concentrations of 2mM, at this concentration tubular 
incorporation was inhibited to 34%.
ADR inhibited proline incorporation to 50 % at a concentration of 
61uM (P<0.0005), at this concentration glomerular adenosine 
triphosphate (ATP) content was unaffected and there was no LDH 
leakage.
Of the total glomerular incorporation of amino acids, 55% of 
proline, 70% of lysine and 14.5% of histidine was incorporated 
into a crude extract of the glomerular basement membrane (GBM).
Glucose oxidation and the pentose phosphate pathway (PPP) were 
shown to be active in isolated rat glomeruli. The PPP was 
demonstrated to be stimulated equally by the redox cycling drug 
paraquat and ADR (3 00 % control by 500uM after 4 hours).
This stimulation can be partially blocked by desferrioxime 
suggesting the involvement of free radicals as part of the toxic 
mechanism of ADR.
The addition of free radical scavengers increased the
free radicals are generated m  the isolation of rat glomeruli. 
The addition of free radical scavengers during isolation may 
reduce this damage.
Thus isolated glomeruli remain viable for at least 4 hours. 
Selectivity for in vivo glomerular toxins was demonstrated in 
vitro for some toxins e.g ADR. Proline incorporation appears to 
be a a sensitive indicator of toxicity and this was not ATP 
(energy) dependent, this is likely to be free radical mediated 
although not prevented by the addition of all free radical 
scavengers.
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apparent vulnerability is explained, in part, by the small mass 
of the organ in relation to the volume of blood processed (25% of 
the cardiac output) and the variety of active metabolic processes 
that represent its normal function. The elucidation of the 
mechanism by which a xenobiotic induces its target cell toxicity 
in-vivo is compounded by the nature of the organ. It has long 
been established that there is metabolic, functional and 
structural heterogeneity both along and between nephrons. The 
cellular target for xenobiotic toxicity is therefore a function 
of these properties. This heterogeneity can result in the 
modification of specific markers (released by the damaged cells) 
by adjacent unaffected cells, thus making interpretation of 
toxicological data very complex. The situation is further 
complicated by the massive functional reserve in the normal 
kidney. This is utilised to maintain an apparently normal renal 
function until the ability of the kidney to compensate is 
exceeded. Thus in-vivo attempts to evaluate nephrotoxicity may 
not detect the primary functional and structural changes which 
are likely to be of clinical significance. It may therefore be 
advantageous to investigate the mechanism of action of a 
particular toxin in-vitro on the specific cell type.
Despite, the involvement of the glomerulus in disease processes 
(e.g.immune complex glomerulonephritis, see Tornroth and 
Skrifvars, 1975) and in xenobiotic-induced toxicity (e.g. 
hydrocarbon associated glomerulonephritis, Lock, 1984) the 
glomerulus has not been fully characterised as an area of
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selective kidney toxicity. The study of the glomerulus is further 
merited by its importance in controlling many of the normal 
functions of the rest of the nephron. It is the principal route 
by which a xenobiotic that is not protein bound may go from the 
vascular to the intratubular compartment. The glomerulus also 
controls the perfusion pressure by its ability to change the 
diameter of the capillaries in the glomerular capillary bed. 
This is achieved by the contraction and relocation of the 
mesangium, a function that can be modulated by various blood 
borne physiologicial messengers (e.g. adrenalin, angiotensin). 
Therefore, any change in the ability of the glomerulus to carry 
out its normal function is likely to adversely affect the rest 
of the nephron.
1.1 Morphology
The glomerulus consists of at least four distinct types of cells:
(i) endothelial (ii) glomerular epithelial, (iii) parieta!l 
epithelial and (iv) mesangial. The anatomic relationship of these 
cells is shown in Figure 1.
Figure 1. Diagramatic representation of the glomerulus showing 
the anatomic relationship of the cells and the GBM (glomerular 
basement membrane) .
^BASEMENT MEMBRANE
M = Mesangial cell.
CL = Capillary Lumen.
P = Podocyte (Epithelial cell). 
E = Endothelium.
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centre of which is a mass of cells collectively called the 
mesangium. These capillaries are surrounded by a gelatinous 
fibrillar matrix which is unique to the glomerulus and has been 
named the glomerular basement membrane (GBM). The properties, 
role and synthesis of this substance are discussed later in this 
chapter. The basement membrane is in turn surrounded by 
epithelial cells which form a complex network with their numerous 
foot processes, these in turn give rise to smaller processes 
(podocytes) which are partially embedded in the lamina externa of 
the GBM.
These foot processes form close interdigitating associations 
resulting in the formation of slits which are 20-30nm apart. 
This gap is closed by a thin membrane called the slit diaphragm. 
This membrane contains within it "pores" which are 4 by 14nm 
(about the size of an albumin molecule) . The slit diaphragm and 
the epithelial cells represent the only "mechanical" barrier 
between the blood and the tubular lumen.
1.2 Mesangial Cells
The morphology of the mesangial cell distinguishes it from its 
neighbouring endothelial cells and reflects some of the functions 
attributed to it.
1.2.1.The Nucleus. The nucleus of mesangial cells are round or 
oval and contains a light chromatin pattern, whereas the 
endothelial cell contains a distorted nucleus which is darker
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nuclear bodies contained within the mesangial nucleus further 
distinguish it from the endothelial nucleus.
1.2.2.The C v t o o l a s m . The cytoplasm of the mesangial and 
endothelial cells differ both in their constituents and the 
quantity of these constituents. The mesangial cells contain 
granules and fibrillar bundles that resemble myofilaments, near 
the edge of the cell membrane (Latta and Maunsbach, 19 62) . The 
endothelial cells do not contain granules. Both mesangial and 
endothelial cells contain mitochondria and ribosomes, but these 
are fewer in number in the mesangial cells where the mitochondria 
are also shorter. The cytoskeleton also differs in that the 
mesangial cell is less compact and therefore appears lighter 
(Latta and Maunsbach, 1962).
Mesangial cells have also been shown to possess vacuoles 
containing carbohydrate material (Latta, 1961) which resembles 
the mesangial extracellular matrix. This implies that the 
mesangial cells synthesise and secrete the mesangial matrix.
1.2.3.Mesangial Cell Function. A surprisingly large number of 
functions have been attributed to mesangial cells, not all of 
which are well established. These include:-.
(i) Phagocytosis (Farquhar and Palade, 1962).
(ii) Contractility (Huhn et al, 1962; Ausiello et al, 1980; 
Barger and Herd, 1971; Barger and Herd, 197 3 and Brenner et al,
1981).
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(iv) Collagen synthesis (Latta, 1961).
(v) Mechanical support (Donihue and Boldesser, 1963)
(vi) Immune activity (Schreiner et al 1981; Schreiner and Cotron 
1982).
fi) Phagocytosis. Although this function has been attributed to 
mesangial cells, cultured rat mesangial cells do not phagocytose 
a wide variety of materials (Kreisberg et al 1978). It has been 
suggested that there are a number of mesangial cell types: one of 
which is non-phagocytic and this is the type predominant in 
culture conditions (Kreisberg and Karnovsky 1983). Phagocytic 
cells can be isolated from rat glomeruli (Canozine et al 1976) 
and these have been shown to possess receptors for C3b complement 
binding protein and Fc region of antibodies, as well as other 
features characteristic of monocytes. It was therefore proposed 
that the phagocytic cell type were in fact blood borne 
monocytes, which enter the mesangium to clear debris (Karnovsky 
and Kreisberg, 1980 ? Kreisberg and Karnovsky, 1982).
(ii) Contractility. • The major morphological indication that 
these cells have contractile activity is the presence of actin 
and myosin filaments, as demonstrated by immuno-fluorescence 
microscopy (Scheinman et el, 1976; Scheinman and Fish, 1978; 
Foidart et al, 1981). Actin and myosin have been shown to exist 
in non-muscle cells in culture (Lazarides and Weber, 1974; 
Pollock et al, 1975; Fujiwara and Pollard, 1976). So this
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activity to mesangial cells. However, cultured mesangial cells do 
also exhibit other properties of smooth muscle cells in-vitro; 
for example they grow in a swirl-like fashion (Kreisberg and 
Karnovsky, 1982) and pile in culture to form the distinctive 
hills and valleys characteristic of smooth muscle cells in 
culture (Gimborne and Cotron, 1975). Cultured mesangial cells 
are growth-stimulated by "platlet derived growth factor" (Striker 
et al, 1980) as are smooth muscle cells.
This uncertainty about the contractile ability of the mesangium 
has recently been resolved using time lapse cine-microscopy, 
where whole isolated human glomeruli were shown to pulsate 
(Brenik, 1969).
It has been suggested that this contractile ability of the 
mesangium plays a physiological role in the control of 
glomerular size and hence blood flow (Ausiello et el, 1980; 
Brenner et al, 1981). The contraction of the mesangium would 
result in a reduction of capillary surface area and thus the 
glomerular filtration rate (Brenner et al, 1981). This 
hypothesis has been further strengthened by the fact that the 
contractile activity can be regulated by many hormones and 
locally generated autocoids eg. angiotensin II (Blantz et al, 
1976), arginine vasopressin (Ichikawa and Brenner, 1977), 
parathyroid hormone (Ichikawa et al, 1976), prostaglandin E2 
(Baylis et al, 1976), prostacyclin (Schor et al, 1981) and 
dibutyryl cyclic AMP (Ichikawa and Brenner, 1977). Mesangial 
cells also bind angiotensin II specifically, and this may be
6
iii) Secretion. The mesangium is continuous with the Lacis cells 
of the juxta-glomerular apparatus a renin secreting unit (Latta 
and Maunsbach, 1962) . It has for example, been demonstrated 
(Donihue and Boldesser, 1963) that under certain physiological 
conditions, such as bilateral adrenalectomy (resulting in 
mineralocorticoid deficiency) agranulated mesangial cells develop 
cytoplasmic granules resembling those present in Juxta-glomerular 
cells. Furthermore, isolated glomeruli have been shown to 
produce renin (Beierwaltes et al, 1980). This property is 
retained by a sub-populations of cultured cells which have been 
demonstrated to possess renin-like activity i.e. convert 
angiotensinogen to angiotensin I (Karnosky and Kreisberg 1980? 
Kreisberg and Karnovsky, 1982).
It is possible that the secretory property of mesangial cells may 
be involved in the regulation of vasoactivity at the level of 
individual capillary loops. This would allow a very fine control 
of glomerular filtration.
iv) Collagen Synthesis. Normal glomeruli have not been reported 
to contain type I and type III collagen. Although there have been 
reports suggesting mesangial cells may synthesise the thin 
collagen layer with which they are closely associated (Latta, 
1961; Latta and Maunsbach, 1962; Pease and Molinari, 1980) this 
is predominantly type IV. However, mesangial cells in culture 
(both human and rat) synthesise and excrete types I and III 
collagens in addition to type IV collagen (Striker et al, 1980?
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1980). These collagens also accumulate In tne mesangium m  
disease states e.g. diabetes mellitus (Scheinman et al, 1978b). 
This suggests that the ability of mesangial cells to synthesis 
collagen of types I or III is latent and may represent a 
deviation from normal physiological activity.
v) Support. It has been suggested (Donihue and Boldesser, 1963) 
that one function of the mesangium is to provide support for the 
glomerular capillary bed. This is not an unreasonable suggestion 
as the intracellular network of actin and myosin filaments 
together with other tubular and filamentous structures provide 
sufficient rigidity for this function. However, the biochemical 
properties of these cells are too diverse for this to be 
considered their sole function.
vi) Immune Activity. It has been reported that an inherent 
population of glomerular mesangial cells had the potential to 
process antigens and initiate cellular immune responses in situ 
(Schreiner et al, 1981; Schreiner and Cotron, 1982). These cells 
are la positive, that is, they bear I-region associated antigens 
which allow specific interactions between phagocytes and 
lymphocytes. The fact that these cells possess immune activity 
is firmly established (Schreiner et al, 1981? Schreiner and 
Cotron, 1982; Latta and Maunsbach, 1962? Kreisberg and Karnovsky,
1982). These cells have many of the characteristics of 
mononuclear cells. This indicates that they are likely to be the 
same population of cells mentioned earlier as possessing 
phagocytic properties. They increase (60 times normal) in the
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they are immuno-reactive phagocytic cells (i.e. monocytes).
If all these proposed characteristics were in fact part of the 
normal functions of one population of mesangial cells then it 
would indeed be a versatile and undifferentiated cell unlike 
other glomerular cells. It is therefore believed that the 
mesangium consists of at least two distinct sub-populations (each 
of which has several functions which may be further specialised). 
The two main types of cells are thought to be:-
1) a bone marrow derived cell which has the properties of a 
mononuclear cell (eg., phagocytosis, immune reactivity and la 
surface antigens); and
2) a cell that resembles smooth muscle and has the contractile, 
supportive and synthetic abilities previously discussed.
This is a viable suggestion because evidence from cell culture 
shows that many of the properties of mesangial cells are lost in 
culture. These lost properties correspond to the phagocytic 
mononuclear type of cells. This would be consistent with the fact 
that different cell types require different culture conditions 
and any particular cell type may be selected for or against by a 
particular set of culture conditions.
Observations using injected thorotrast (thorium dioxide) granules 
have revealed channels which have a rapid and extensive flow of 
blood plasma (Latta and Maunsbach,1962; Latta et al, 1960). 
Further, ultrastructural studies by Latta and Fligiel, (1985) 
demonstrated fenestrations (3760 x 6260nm) within the endothelium 
of the capillaries which open directly on to the mesangial
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mesangium and rapid flow (of fluid) out. A number of differant 
pathways have been suggested for plasma flow between capillary 
lumen and mesangial channels. One such pathway is through the 
extracellular matrix, basement membrane and epithelial foot 
processes (covering the mesangium between capillary loops) into 
the urinary space (Latta, 1970; Latta, 1980). This results in 
deposition of particles at the basement membrane which may be 
later removed by mesangial phagocytes. Another pathway may be 
directly into the efferent portions of the glomerular capillary 
loops (Latta and Maunsbach, 1962) . A third possible route is 
through to the juxta-glomerular apparatus (Latta and Maunsbach, 
1962), but this represents only a small portion of mesangial 
flow. Other possibilities include intra- or extra-cellular 
digestion of filtered particles (Mahieu et al, 1980; Nakashima et 
al, 1980). Undigestible particles can remain in the mesangium 
for months (Latta, 1980).
1.2.4.Biosynthetic Profile 
The biosynthetic profile of the bone marrow derived mesangial 
cells is unknown. This is mainly due to an inability to isolate 
viable cells of this' type in large enough quantities to perform 
conventional metabolic studies that typically require 106 cells. 
The smooth muscle type mesangial cells are easier to isolate, 
culture and study, and their biology has therefore been more 
extensively described. The contractile response of these cells to 
a number of naturally occuring pharmacological agents has already 
been described in this chapter.
10
stimulates mesangial cell growth and proliferation in rabbits 
(Nakashima et al, 1980) and in human (Striker et al, 1980) 
glomerular culture. Other reports suggest that the cells which 
are stimulated by PDGF are not mesangial but endothelial (Striker 
et al 1984). This is consistent with the earlier observations of 
Nakashima et al, 1980, who also observed increased endothelial 
growth in rabbit glomerular culture. Striker and Striker 1985 
have reported that they have been unable to find PDGF receptors 
on mesangial cells, thus unless there is an effect on mesangial 
cells that is not receptor mediated, it appears more likely that 
PDGF stimulates endothelial cells.
Human mesangial cell proliferation has been reported to be 
increased by the addition of macrophage supernatant (Melcion et 
al, 1982 ; Wagner et al, 1983). The supernatant contained a 
complex mixture of macrophage products, The exact nature of the 
stimulatory product has therefore been difficult to established. 
Although studies have suggested that the effect may be partially 
due to Interleukin-I (Striker et al, 1980). This hypothesis has 
been further strengthened by the observation that rat mesangial 
cells produce an autocrine substance resembling Interleukin-I 
(Lovett et al, 1983). The presence of which increased total 
protein and collagen synthesis by mesangial cells. Reports on 
the effects of macrophage products on mice mesangial cells are 
contradictory. Both decreased (Ooi et al, 1983) and increased 
cell proliferation (Wagner et al, 1983; Dubois et al, 1981) have 
been reported. This is probably due to the difference in
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As mentioned above glomerular mesangial cells (of several 
species, including rat, man and pig) synthesize a number of 
interstitial and extracellular collagens. Like smooth muscle, 
cells type I collagen is synthesized to a greater extent than 
type III, but mesangial cells differ from smooth muscle cells in 
that type IV collagen is synthesised in the largest quantity 
(Striker et al, 1980).
In addition to the synthesis of type I, III, and IV collagen the 
mesangial cells have also been shown to synthesise a number of 
glycosaminoglycans including heparin sulphate, chondroitin-4- 
sulphate, chondroitin-6-sulphate and dermatan sulphate. The 
major glycosaminoglycans within the mesangial cell were 
chondroitin-4-sulphate and chondroitin-6-sulphate. Heparin 
sulphate was present only in small quantities and dermatan 
sulphate was found almost exclusively in the medium (Striker et 
al, 1980? Foidart et al, 1980). Sulphated glycoproteins in the 
region of 210,000 daltons (including f i bronectin and a 
glycoprotein designated as GP-2) have also been reported to occur 
within mesangial cell cultures (Killen and Striker, 1979? Oberley 
et al, 1979,1981). Glycos-aminoglycans are negatively charged 
molecules which form the charge selective barrier known as the 
"glomerular polyanion". The importance of the glomerular 
polyanion to permeability has been demonstrated (Caulfield,
1979) .
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Both rat and human mesangial cells synthesise and excrete 
arachidonic acid products. Human mesangial cells do not, however, 
synthesise large quantities of cyclo-oxygenase products. PGE2 , 
PGF2alpha and PGI2 hut not thromboxane A 2 are synthesized 
following stimulation with arachidonic acid (Ardaillou et al,
1983). There is no stimulation by angiotensin II, cyclic AMP or 
ionophores. The same prostaglandins are produced, by rat 
mesangial cells, but in much larger amounts. The relative amounts 
produced are as follows PGE2 > PGI^alpha > PGI2 (Scharschmidt and 
Dunn, 1983; Schlondorff et al, 1983; Sraer et al, 1982a,1982b). 
This prostaglandin production is stimulated by angiotensin II, 
and the calcium ionophore A23187, but the mechanisms of induction 
differs. A n giotensin II operates by a c t i v a t i o n  of a 
phosphatidylinositol specific phospholipase C, whereas A23187 
induces calcium entry into the cell, resulting in activation of 
non-specific phospholipidosis (Schlondorff et al, 1985). Rat 
mesangial cells in culture have been reported to produce 12- 
Hydroxyeicosatetraenoic acid (12-HETE) which was detected in the 
culture medium (Jim et al, 1982).
1.3.Endothelial Cells
The endothelial cells, line the glomerular capillary wall. These 
are characterised by the presence of fenestrae approximately 100 
nm in diameter. These cells possess a negatively charged 
glycosaminoglycan coat which is thought to participate in the
13
situ morphology of glomerular endothelial cells has already been 
discussed in relation to the mesangium with which they are 
closely associated.
The properties of isolated endothelial cells have not been well 
characterised, because although endothelial cells (positively 
identified by the presence of factor VIII antigen) have been seen 
emerging from cultured glomeruli, their isolation and subsequent 
propogation into homogeneous culture has proved difficult 
(Scheinman et al, 1976; Ausiello et al, 1980; Karnovsky and 
Kreisberg, 1980; Kreisberg and Karnovsky, 1982). Striker et al, 
1984, have reported the successful culture of human endothelial 
cells. This was achieved by modification of the culture medium 
to include platlet derived growth factor (PDGF) (Waymouth's 
medium supplemented with 2 0% foetal bovine serum and 2 ng/ml 
PDGF). These data represent the only source of information on 
cultured glomerular endothelial cells. These cells never 
became elongated or stellate, they therefore differed from 
mesangial cells. The cultures were reported to form confluent 
monolayers having a cobblestone appearance similar to glomerular 
epithelial cells. Twenty per cent of these cells possessed cyto- 
keratin and were considered to be epithelial. Actin and tubulin 
were present with a regular distribution and the cells contained 
an abundant cytoskeleton poss e s s i n g  m i c r o t u b u l e s  and 
microfilaments.
Although factor VIII antigen was present, Weibel-Palode bodies, a 
marker for endothelial cells, were not present in these cells but
14
bodies witnin giomeruiar enaotneiium in vivo eu a ± ,
1984).
1.4.Epithelial Cells
Epithelial cells in-vivo are readily identified by their 
characteristic morphology. This includes numerous foot processes 
which form a complex interdigitating network. In culture, These 
cells adhere to the surface of the culture vessel where much of 
this morphology is lost (Andrew and Coffey, 1980? Burlington and 
Cronkite, 1973). However, glomerular epithelial cells have been 
isolated in pure cultures by a number of workers (Ausiello et al, 
1980; Kreisberg and Karnovsky, 1982; Karnovsky and Kreisberg, 
1980; Scheinman et al, 1976; Atkin et al, 1980; Kreisberg et al,
1982) and this has allowed the cell to be well characterised.
In culture the epithelial cell is identified by the following 
characteristics: it has a polyhedral shape and confluent cultures 
have a cobblestone appearance when viewed under phase contrast 
(Killen and Striker, 1979? Kreisberg et al, 1978; Kreisberg and 
Karnosky, 1982? Kreisberg et al, 1982; Scheinman et al, 1978? 
Foidart et al, 1979). Ultrastructurally the cells possess cilia 
on their surface (Kreisberg et al, 1978) and form junctional 
complexes (Kreisberg et al, 1978 ;Foidart et al, 1979 ).
Puromycin aminonucleoside causes a cytotoxic response in rat 
glomerular epithelial cells (Kreisberg et al, 1978; Kreisberg and 
Karnovsky, 1983; Fishman and Karnovsky, 1985? Foidart et al,
1980) but not those from human (Striker and Striker, 1985) or
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demonstrated that these epithelial cells contain large nuclei 
with two or more nucleoli. The cytoplasm contains many elongated 
mitochondria and profiles of rough and smooth endoplasmic 
reticulum as well as abundant polysomes. Other bodies containing 
debris and myelin figures are also present. As well as the 
characteristic cilia the cell surface is covered with numerous 
short bleb like microprojections. Striker and Striker, 1985 
report that using a monoclonal antibody they have found an 
abundance of cytokeratin, which was evenly distributed in regular 
filaments from the periphery of the nucleus to the cell membrane. 
They also reported the absence of vimentin and the presence of 
actin containing microfilaments. It has been suggested that these 
microfilaments confer a contractile ability to glomerular 
epithelial cells (Andrew and Coffey, 1983).
A number of other antibodies directed at epithelial cell antigens 
have been used in their identification. One such antibody is PHM5 
(Burkholder et al, 1977) which was obtained by immunising mice 
with whole glomeruli. This antibody is selective for podocytes 
(epithelial cells) and was assumed to recognises a macromolecule 
(unidentified) associated with the cell surface polyanion as the 
antigen.
Another antigenic determinant which has been used as a marker for 
epithelial cells is the C3b receptor. Although this receptor has 
been demonstrated on human glomerular epithelial cells in-situ, 
its presence on cultured epithelial cells is controversial. It 
has been reported that both human and rat glomerular epithelial
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Kreisberg and Karnovsky, 1982; Karnovsky and Kreisberg, 1980; 
Klllen and Striker, 1979; Burkholder et al, 1977), whereas this 
receptor is reportedly lost (or did not exist) in culture (Atkin 
et al, 1980; Scheinman et al, 1978; Foidart et al, 1979). The 
presence of C3b receptors on glomeruli in-vitro is not conclusive 
(Kreisberg et al, 1978), their appearance (or lack of) may depend 
upon the particular culture conditions used (Scheinman et al, 
1978; Foidart et al, 1979).
1.4.1.Biosynthetic profile.
1.4.1.1.Glomerular Basement Membrane synthesis
This is the most widely studied aspect of the glomerulus and 
therefore the epithelial cells. The glomerular basement membrane 
(GBM) is composed of both collagenous and non-collagenous 
components (Kefalides, 1978). The collagenous component is 
secreted in the form of type IV procollagen and is deposited 
without further reduction (Kefalides, 1978). A smaller amount of 
type I collagen has also been reported to be synthesised by 
epithelial cells in culture (Striker and Striker,1985). The 
glycosaminoglycan (GAG) heparin sulphate is the principal non- 
collagenous component of the GBM synthesized by epithelial cells 
(Atkin et al, 1980; Scheinman et al, 1978; Foidart et al, 1979). 
This highly negatively charged molecule has been shown to be 
important in restricting the passage of negatively charged macro­
molecules across the GBM (Kanwar and Farquhar, 1979c; Kanwar et 
al, 1980). Chondroitin-4-sulphate and chondroitin-6-sulphate are
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greater extent than chondroitin-6-sulphate in epithelial cells. 
Although fibronectin has been reported to be synthesized by 
epithelial cells (Striker and Striker, 1985; Scheinman et al, 
1976; Foidart et al, 1980; Oberley et al, 1979), the exact 
location of this glycoprotein is controversial (Fish et al, 1975; 
Courtoy et al, 1980; Houser et al, 1982; Scheinman et al, 1979; 
Courtey et al, 1980; Oberley et al, 1979).
1.4.1.2.Arachidonic acid metabolism in epithelial cells.
Human glomerular epithelial cells appear to differ from rat cells 
in that they do not produce cyclo-oxygenase products in the 
resting state or after stimulation by A23187, angiotensin II, 
cyclic AMP and arachidonic acid (Ardaillou et al,1983). Studies 
using early cellular growths from rat glomerular explants 
(presumed to have been predominently epithelial in nature) have 
indicated synthesis of prostaglandin E2 (PGE2) and Thromboxane A2 
(TBX A 2 ) increased synthesis of both prostanoids could be 
demonstrated by stimulation with angiotensin II, cyclic AMP, 
A23187 and arachidonic acid (Aradaillou et al, 1983).
Purer cultures of epithelial cells have demonstrated PGI2 to be 
the principle prostanoid synthesised in epithelial cells 
(Kriesberg et al, 1982b). This was at least one order of 
magnitude greater than that produced by mesangial cells. The 
only lipoxygenase pathway product of these cells which has been 
reported is 12-Hydroxyeicosatetraenoic acid (Jim et al, 1982) .
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This is probably the most extensively studied aspect of the 
glomerulus, but the exact biochemical structure, the role of 
various components and the cells involved in its synthesis are 
not yet fully understood. The current understanding of the GBM is 
summarised below.
The GBM is between 250 and 350 nm thick in the normal human 
glomerulus. It appears by electron microscopic examination to be 
composed of three layers. An electron dense layer in the middle 
(the lamina densa) with less dense layer (lamina densa externa) 
on the epithelial side and another less dense layer (lamina densa 
interna) on the endothelial side (Moffat, 1982).
The GBM is affected by a number of factors which include:
i) Age
ii) Disease
iii) Toxic Agents
1.5.1.Age and the GBM.
It has been reported that between birth and 3 years of age, the 
human GBM changes its immunological character considerably (Anand 
et al, 1978). There is also an age related increase in thickness 
(Moffat, 1982). This is consistent with the increased amount of 
hydroxylation of proline and lysine (Langeveld et al, 1980). The 
latter also suggests a change in the distribution of collagenous 
components in the human GBM with age.
1.5.2.Disease and The GBM.
The GBM has been demonstrated to be modified in a number of
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1.5.2.1.Hereditary Diseases
In Alports syndrome, there are segmented changes in the thickness 
of the GBM. The lamina densa loses its regular ribbon like 
appearance and becomes split into interwoven strands (Hinglais et 
al, 1972? Spear and Slusser, 1972? Churg and Sherman, 1973). In 
Familial Benign hematuria, which is a peculiarity as opposed to a 
disease, since the only symptoms are a microscopic hematuria but 
no proteinuria or renal failure, the subject invariably has thin 
(100 nm as compared to normal 250-350 mn) GBM (Hill et al, 1974? 
Rogers et al, 1973). Nail-patella syndrome (Hereditary onycho- 
osterodysplasia) is a rare disease which is characterised by 
hypoplasia and/or displasia of fingernails and associated 
widespread skeletal changes. The GBM of such patients undergoes 
an irregular thickening and focal bundles of collagen like fibres 
appear within electron lucent areas of the GBM (Ben Bassat et al, 
1971? Hoyer et al, 1972? Bennet et al, 1973).
1.5.2.2.Non-Hereditarv Diseases
Many immune related diseases such as Berger's disease (IgA 
nephropathy), Henoch-Schomlein purpura, lupus nephritis, and 
post-streptococcal glomerulonephritis (GN) give rise to changes 
in the GBM (Rosen et al, 1973? Habib et al, 1973? Tornroth and 
Skrifvars, 1975). These changes are classified morphologically 
into different types of glomerulonephritis namely:
1) Membraneous GN
2) Membranoproliterative GN
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4) Focal Glomerular Sclerosis
All these different types reflect various patterns of GBM 
reaction to immunologic injury. The same lesion can be the 
result of a variety of different immunologic insults.
1) Membraneous Glomerulonephritis
This disease is characterised by a thickening of the capillary 
walls. This may be due to an increase in the thickness of the 
GBM (up to 10 times normal). The disease is characterised by 
immune deposits at the GBM surface. Further deposition sees the 
deposits embedded in the lamina densa and the GBM is irregular in 
its thickness. As the disease progresses, the GBM is covered by 
a new lamina densa layer.If the disease regresses, the deposits 
are reabsorbed on the endothelial side and a new regular lamina 
densa is formed. The involvement of GBM turnover is implied but 
the exact nature is unclear (Tornroth and Skrifvars, 1975).
2) Membranoproliterative GN
Typically, this is characterised by a thickening of the 
capillary walls which may be the result of the abnormal immune 
deposits and/or the mesangial proliferation. This disease has 
been classed into two types: Type 1 is characterised by deposits 
on internal (subendothelial) side of the GBM; and Type 2 which is 
identified by dense deposits within the GBM. This GBM can be up 
to 60 times the normal thickness but appears to be normal 
otherwise. It has been suggested that this thickening is due to 
increased synthesis of basement material by the proliferating
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3) Crescentic GN
This disease is characterised by cresent formation which may be 
the result of the proliferating Parietal epithelial cells with 
some macrophage involvement (Morita et al, 1973; Stejskal et al, 
1973; Min et al, 1974; Thompson et al, 1979). The most striking 
observation in this disease is the almost complete loss of GBM. 
This obviously results in a massive loss of blood cells and 
plasma content into the urinary space. The mechanism of this 
disease has not yet been elucidated (Morita et al, 1973; Stejskal 
et al, 1973; Min et al, 1974).
4) Focal Glomerular Sclerosis
Diffuse podocyte changes such as loss of foot processes and 
hyaline deposition characterise this disease. The rest of the 
glomerulus appears normal. There is occasional synthesis of new 
GBM material on either side of the apparently normal GBM 
(Grishman and Chung, 1975).
1.5.3.Toxic agents and the GBM.
A number of compounds including puromycin aminonucleoside 
(Fishman and Karnovsky, 1985; Schreiner et al, 1981), polybrene 
or hexadimethrine (Moffat,1982) and adriamycin (Weening and 
Renneke, 1983) have been shown to associate with the anionic 
sites present in the GBM and on podocytes. In rats with alloxan- 
induced diabetes the GBM has been shown to be increased in 
thickness (Evans and Luft, 1980).
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The GBM is composed of both collagenous and non-collagenous 
components (Kefalides, 1978). The collagen is predominantly of 
type IV (Courtoy et al, 1980; Houser et al, 1982; Scheinman et 
al, 1979), but cultured mesangial cells have been shown to
produce small amounts of type I and type III collagens (Striker 
and Killen, 1980). The non-collagenous components include 
fibronectin (Fish et al, 1975; Courtoy et al, 1980; Houser et al, 
1982; Scheinman et al, 1979; Courtoy et al, 1980), Laminin 
(Courtoy et al, 1980; Scheinman et al, 1979 ), entactin (Brender 
et al, 1981) and sulphated g l y cosaminoglycans. The major 
glycosaminoglycan (GAG) in the GBM is heparin sulphate (Striker 
et al, 1980) although chondroitin-6-sulphate, chrondroitin-4- and 
dermatan sulphate have been shown to be synthesised by glomerular 
cells in culture (see individual cells discussed earlier).
These GAGs are highly negatively charged and their importance in 
restricting the passage of negatively charged macromolecules has 
been demonstrated (Kanwar and Farquhar, 1979c; Kanwar et al, 
1980). The cell type(s) that is/are responsible for the 
synthesis of the GBM has been the subject of a large number of 
studies. It is now known that at least in isolation, each of the 
cells produce various components of the GBM. The in-vivo 
significance of this is not as yet clear. Attempts using silver 
nitrate solutions (administered for long periods resulting in 
deposition of silver labelled granules in the GBM) have suggested 
that the epithelial cells continuously synthesize GBM material 
which is degraded at the endothelial side (Kurtz and Feldman,
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demonstrated that silver nitrate administration induces abnormal 
conditions (Striker and Smuckler, 1970). In autoradiographic 
studies using 3H-Proline it has been suggested that both visceral 
epithelial and endothelial cells play a significant role in the 
synthesis of GBM (Nayyar et al, 1980) . In the same study it was 
proposed that the role of the epithelial cells was greater than 
that of the endothelial cells. The mesangial cells were said to 
ingest the GBM material degraded at the endothelial side.
Schurer et al, 1980 have proposed a model of the GBM based on the 
size of the tropocollagen and taking into account the above 
mention biochemistry and the observations of other authors. 
These include: the size of slit diaphragm pores to be 4 x 10 nm 
(Rodewald and Karnovsky,, 1974). Negative charges on both 
endothelial and epithelial sides (Venkatachalam et al, 1978) 
which are at the sites of junctions in the fibrillar network 
(Kanwar and Farquhar, 1979a,1979b, Caulfield, 1979; Latta et al, 
1975; Arthurson et al, 1979; Schurer et al, 198 0; Holdsworth et 
al, 1978; Taub and Sato, 1980; Oberley et al, 1981; Striker et 
al, 1976; Foidart et al, 1981;). Collagen type IV is present in 
the GBM (Kefalides, 1978) particularly in the lamina densa (Latta 
et al, 1975). There are pores in the GBM ranging from 2.6 - 4.1 
nm (Arthurson et al, 1979). There is a functional albumin layer 
at the endothelial side (Ryan and Karnovsky, 1976). The model is 
illustrated in Figure 2. It is suggested that GBM collagen is 
synthesized by epithelial cells and is present on the surface in 
a staggered organisation as in fibrillar collagen. A large
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aggregation of collagen molecules with matrix proteins. These 
matrix proteins bind GAGs and thus anionic charges are present at 
binding sites. Continuous production of GBM material results in 
movement of old material towards the endothelial side. The 
glycocalyx which covers the epithelial cells and the secreted 
disaccharides prevent crosslinking of the tropocollagen 
molecules. As the GBM material moves towards the endothelial 
side it moves out of the sphere of influence of this "gel" 
resulting in an increase in crosslinking. This in turn leads to 
tightening of the meshwork. As the GBM material approaches the 
endothelium it is degraded by a mechanism which has not yet been 
elucidated. The resulting fragments are reabsorbed by epithelial 
cells or are further digested by cells within the mesangium.
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Figure 2. A model of the glomerular basement membrane as 
suggested by Schurer et. al. 1980.
Isolated glomeruli are mainly decapsulated and therefore do not 
possess the parietal epithelium which forms the Bowman's capsule.
1.7. Aims and objectives.
The glomerulus is exposed to a great number of toxins. Indeed,
most toxins entering the nephron have first passed through the
glomerulus. The glomerulus, in-vivo, appears to be unaffected by
most of these agents but is selectively damaged by some. Because
of the dynamics of the in-vivo situation it's difficult to assess
whether the effect of a particular compound on a cell is due to a
direct action of that compound on that cell or the result of an
interaction with another cell (or organ system). The objectives
of this project were to examine the effects of a number of
nephrotoxic agents on the isolated glomerulus. Isolated viable
glomeruli from both rat and pig were studied. The compounds
selected for study and their in-vivo target within the kidney are
summarised in Table 1.
COMPOUND SITE OF ACTION
Puromycin aminonucleoside Glomerular
Epithelial cells
Streptomycin sulphate Proximal tubules
Polybrene (hexadimethrene) Distal tubules
Bromoethenamine Papilla
Adriamycin Glomerular
epithelial cells
Table 1.
Compounds studied and their reported in-vivo sites of action.
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Puromycin aminonucleoside is a derivative of puromycin. Puromycin 
is used clinically as an antineoplastic and antiprotozoal 
(trypanosomal). It was first isolated from the soil actinomycete 
Streotovces alboniaer. Puromycin is now produced synthetically 
and its chemical structure is shown below. Puromycin exerts its 
therapeutic activity by interfering with protein formation by 
affecting the function of RNA in the cells concerned.
OH
Streptomycin is an antibiotic produced by the soil actinomycete 
Streptomvces qriseus its mechanism of action is thought to be by 
inhibition of protein synthesis. The chemical structure is shown 
below.
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Adriamycin (doxorubicin) is an antibiotic isolated from 
Streptomvces peucetius var caesius. it is used therapuetically as 
an antineoplastic agent. It is thought to exert its action by 
intercalating with DNA although there is evidence to suggest that 
the drug can be actively cytotoxic without entering the cell. The 
chemical structure of adriamycin is shown below.
0 OH
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adriamycinone
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HO
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Polybrene (hexadimethrene bromide) is a polycationic polymer 
with a molecular weight of 5000-10,000, has been shown to be 
selectively toxic to distal convoluted tubules (Bach et al 1986). 
The chemical structure of polybrene is shown below.
CH. Clio
-n-(ch2 )6- n L _ ( c h 2 )3_
fi„ ' J 213r~C1U CHo
Hexadimethrine Bromide.
Bromoethanamine has been shown to be a selective papillary toxin 
in rats (Bach et al 19 86). The structure of bromoethanamine is 
shown below.
H
H
H
H
M  H
Enzyme leakage, a parameter of gross cell damage has been used 
both clinically (Schmidt and Schmidt, 1976) and in toxicological 
research (Mol et al, 1986). The value of enzyme leakage as an
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enzyme could not be chosen. Five enzymes were chosen to represent 
different cellular compartments of glomerular cells and the 
principal contaminants (proximal tubules). These enzymes were, 
Lactate dehydrogenase a cytoplasmic enzyme, N-Acetyl-beta-D- 
Glucosaminidase and beta-D-Galactosidase which are lysosomal, and 
gamma-glutamyl transpeptidase and alkaline phosphatase (both 
brush border enzymes abundant in the proximal tubules). There is 
evidence that lysosomal enzymes are involved in the normal 
turnover of the glomerular basement membrane (Dean and Barret, 
197 6) . These enzymes have been shown to change in response to 
toxic injury (e.g puromycin aminonucleoside-induced nephrosis, 
Velosa et al, 1980). Puromycin aminonucleoside increases the 
number (predominantly in epithelial cells but also in mesangial 
cells) and the stability of these lysosomes (Caulfield et al, 
197 6). As the GBM is of major importance to normal glomerular 
function any changes in the activity of these enzymes as a result 
of xenobiotic interaction may cause functional damage.
Changes in the normal function of the GBM may represent a 
possible mechanism by which some of the above compounds may 
manifest their toxic action. The synthesis of the GBM proteins 
was studied by following the incorporation of tritium labelled 
proline and lysine. The incorporation of tritiated histidine was 
also studied to see the effects of the compounds on more general 
protein synthesis. The effect on DNA synthesis was followed by 
the incorporation of tritiated thymidine.
Studies with polymorphonuclear leukocytes and macrophages have
(cAMP) inhibits lysosomal enzyme release (Wilscher and Cruchaud, 
1976) and an increase in cyclic guanyl mono phosphate (cGMP) 
induces enzyme release (Ignarro, 1977) . Glomeruli have been 
demonstrated to possess an active cyclic nucleotide system which 
is sensitive to biogenic amines and prostaglandins (Torres et al, 
1978; Shah et al, 1979; Abboud et al, 1979).
The effect of the glomerular epithelial toxin adriamycin was 
studied on isolated glomeruli. The potential of adriamycin to 
form free radicals and the possibility of this as a mechanism of 
action of these compounds was investigated. This involved the 
monitoring of the pentose phosphate pathway which is the major 
site of NADPH synthesis. NADPH is required as a co-factor for the 
reduction of glutathione by the enzyme glutathione reductase. 
Glutathione is oxidised in the process of free radical removal. 
The addition of exogenous radical scavengers, and comparison of 
effects with the known free radical mediated toxin paraquat was 
also investigated.
31
All animals were allowed to acclimatize to the laboratory 
conditions for at least 24 hours to ensure that variables such as 
stress due to transportation, changes in heat, light, humidity 
and diurnal rhythms were minimised. Ten male Wistar rats 
(University of Surrey strain) weighing 150-200g were sacrificed 
by cervical dislocation. The kidneys removed decapsulated and the 
medulla dissected. The remaining cortices were chopped into l-3mm 
cubes in a small amount of
Tyrode's solution (see Appendix I) using a single edged stainless 
steel razor blade (Taab Laboratory Equipment, Reading) on a glass 
plate. The tissue was then placed in about 50ml of oxygenated 
Tyrodes solution and stirred, before it was mechanically 
dispersed.
Aliquots of Tyrode's containing the tissue were then placed on 
the top sieve of a "sieve tower" (see Appendix II) which 
contained a series of four stainless steel sieve's (Endecott's 
Ltd., London) of mesh size 250um, 150um, 125um, and 75um
respectively. The tissue was then forced through the 250um sieve 
using the base of a 10ml conical flask. At this stage the tissue 
fragments were copiously washed with Tyrode's solution at room 
temprature to assist their passage through the first sieve. In 
this way most of the tissue is forced through and only the 
fibrous material remains on the top sieve.
The 150um sieve retains the larger fragments of tissue (which 
were predominantly tubular in nature) and the 125um sieve 
retained the smaller tubular fragments which were not retained
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The glomeruli were harvested from the 75um sieve, and at this 
stage they were about 85% pure in relation to contamination by 
tubular fragments (see below). The glomeruli were washed off the 
sieve into a small beaker using the Tyrode's solution. This 
glomerular preparation was then centrifuged at 115 x g for 3 
minutes. The s u pernatant was discarded and the pellet 
resuspended. This suspension was further centrifuged at 51g for 
2 minutes, the supernatant was discarded and the pellet 
resuspended. The latter centrifugation step was repeated and the 
pellet resuspended in the required volume of Tyrode's solution. 
This glomerular preparation was at least 95% pure (i.e. contains 
5% tubular contamination when examined by phase contrast 
microscopy).
2.2.Isolation of pig glomeruli
The procedure was basically the same as that described for the 
isolation of rat glomeruli. The main changes was necessitated by 
the differences in size of the glomeruli in the two species, and 
also the greater amount of fibrous tissue present in the pig 
kidney as opposed to the rat. The sieves used for the isolation 
of pig glomeruli were 3 00um, 250um, 150um, 125um and 96um (pore 
diameters) respectively. The glomeruli were harvested on the 
125um and 96um sieves. The dissection of the tissue, solutions 
for washing and centrifugation steps, were the same as those 
described for rat glomeruli (see above).
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a glomerular suspension, were examined by a phase contrast light 
microscope, the purity was assessed as a percentage of tubular 
contamination. Initially an improved Neubauer counting chamber 
was used but this was found to be unsuitable because the 
glomeruli were found to be too large to pass under the cover 
slip.
2.4.Assessment of glomerular viability
2.4.l.Ethidium bromide /fluorescein diacetate method.
This assay involved the use of a negatively charged fluorescent 
molecule (ethidium bromide (EB)) and an uncharged fluorescent 
molecule (fluorescein diacetate (FDA)). The negative charge 
present on the surface of cells excluded the entry of EB but 
allowed the FDA to enter freely. On entering, the FDA molecule 
was hydrolysed by non-specific esterases to form fluorescein 
which fluoresces bright green. EB was excluded from cells that 
possess an intact cell membrane, but entered damaged cells where 
it combined with nucleic material and fluoresced bright red 
(Edidu, 1970).
An aliquot (25ul) of.the glomerular suspension was incubated for 
three minutes with 25ul of a solution containing 5ug/ml FDA and 
200ug/ml EB. The glomeruli were observed under appropriate 
illumination for fluorescence. Individual cells on the surface of 
glomeruli were detected as viable (if their cytoplasm fluoresced 
bright green) or non-viable (if the cytoplasm appears weakly 
green and the nucleus appears bright red).
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This assay was based on the measurement of the light emitted as a 
result of a reaction catalysed by firefly luciferase. The amount 
of light produced by a sample was compared with that produced by 
a standard containing a known amount of ATP. The concentration of 
the sample ATP was thus deduced.
The reaction is as follows:
ATP + LUCIFERIN + 02 ^  OXYLUCIFERIN + AMP
+ PPi + LIGHT
The assay reagents were obtained as a kit (No. 1243-102) from LKB 
Wallac. This kit contains two reagents i) the monitoring reagent 
and ii) the ATP standard. The monitoring reagent contains:- 
I) Firefly luciferase
II) D-Luciferin
III) Bovine serum albumin (50mg)
IV) Magnesium Acetate (0.5mmol)
V) Inorganic pyrophosphate (O.lumol)
The ATP standard contained:- 
I) ATP (0.1 umol)
II) Magnesium sulphate (2.0 umol)
The assay procedure was as follows:-
The ATP was extracted from the reaction mixture by the addition 
of 3ml of 5% TCA (w/v). This was allowed to stand at room 
temperature for 10 minutes. The ATP extract (50ul) was added to 
750 ul of Tris-EDTA buffer in a luminometer cuvette. The cuvette 
was transfered to an LKB-Wallac 1250 luminometer where 200ul of
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The standard ATP solution (lOul) was then added to this and the 
increase in light was recorded. The ATP content of the reaction 
mixture can thus be directly extrapolated from the relative light 
emission of the test and standard ATP solutions.
There was a linear relationship between light emission and ATP 
content within the concentration range 10”6M to lO"”11!*.
2.5. Assessment of glomerular damage bv enzyme leakage.
Chemicals were obtained from Sigma Chemical Company Ltd, Poole. 
Where an alternative source was used this is quoted. All 
chemicals were of the highest commercially available grade. 
Glomeruli were freshly isolated as described above. The glomeruli 
were suspended in Tyrode's solution (see appendix I). Aliquots of 
0.5ml of this suspension were added to 0.5 ml solution of the 
test compound to give the required final concentration. The 
mixture was then incubated at 37°C and bubbled with 95% 02 :5% 
C02 mixture for 2 hr. The incubation mixture was removed at the 
end of incubation and placed on ice. This was then filtered 
through glass fibre prefilters to remove the glomeruli. The 
filtrate was then assessed for enzyme content using the methods 
described below.
Untreated controls were used to assess background enzyme leakage. 
Positive controls using sonication (three 3 0 second bursts) to 
disrupt glomerular cells were used to assess total releasable 
enzyme content.
The effect of the compounds on the enzymes were studied by
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presence of the test compounds as described above.
All results are presented as enzyme units/mg glomerular protein 
to allow the collation of multiple experiments.
2.5.1.LACTATE DEHYDROGENASE (LDH1 ASSESSMENT.
Lactate dehydrogenase is a cytoplasmic enzyme and is widely 
distributed in all tissues. There are a variety of iso-enzymes 
which vary from tissue to tissue and this can be used to identify 
the source of the enzyme. LDH was measured by assessing the rate 
of reduction of pyruvate to lactate. This reduction is coupled 
to the oxidation of reduced nicotinamide adenine dinucleotide 
(NADH) which is followed spectrophotometrically in terms of 
reduced absorption at 340nm.
SUMMARY
LDH
pyruvate + NADH -------- —--------------------- ►  lactate + NAD
PROCEDURE
Aliquots (0.05ml) of the enzyme solution were added to 2.85ml of 
a ImM NADH in 0.1M phosphate buffer of pH 7.5,and incubated for 
20 min.at 25°C. Then 0.1ml of 1M sodium pyruvate was added, and 
the mixture transfered to a 1 cm pathlength UV compatible plastic 
cuvette. The absorbance at 340nm was recorded at 30 second 
intervals for 5 min.
CALCULATIONS
The enzyme activity was calculated in SI units, where 1 unit of
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specific conditions. This was directly related to the change in 
absorbance at 340nm.
2.5.2.ALKALINE PHOSPHATASE
Alkaline phosphatase was assayed by the method of Gaven and 
Lavinthal, 1960 in which the reaction velocity was determined by 
measuring an increase in absorbance at 410nm resulting from the 
hydrolysis of p-nitrophenylphosphate to p-nitrophenol.
SUMMARY
Alk.Phos.
p-NITROPHENYLPHOSPHATE + H20 --------- p-NITROPHENOL + PHOSPHATE
(A410nmlow> (A410 high)
PROCEDURE
An aliquot (0.1ml) of the enzyme solution was added to 3ml of a 
ImM p-nitrophenylphosphate in 1.5 M Tris-HCl buffer of pH 8 (at 
25°C). The change in absorbance at 410nm was recorded every 3 0 
seconds for 5 min and a calculation of enzyme activity was made 
using the rate of reaction deduced from the linear portion of the 
reaction curve.
CALCULATION
Enzyme activity was calculated on the basis of one unit of enzyme 
liberates one micromole of p-nitrophenol per min. at 25°C and pH 
8.0 under the specific conditions.
2.5.3.GAMMA-GLUTAMYL TRANSPEPTIDASE
The enzyme, classified as an exopeptidase, cleaves the terminal
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group. It is also called a carboxypeptidase. The assay procedure 
was that of Naftalin et al, 1969. Briefly, gamma-L-glutamyl-p- 
nitroanilide (a synthetic substrate) provides the carboxyl group 
and glycylglycine acts as the acceptor. Once the glutamyl group 
has been hydrolysed, the p-nitroanilide was diazotized. This was 
then measured by the absorbance at 540nm.
SUMMARY
L-GLUTAMYL-P-NITROANILIDE + GLYCYLGLYCINE
------------ m - P-NITROANILINE + GLUTAMYLGLYCYLGLYCINE
P-NITRO ANILINE + NaN02 --------------:------- DIAZO COMPOUND
DIAZO COMPOUND + N- (1-NAPHTHYL) -ETHYLENEDIAMINE ► P I N K  AZO DYE
(A530-550nm)
PROCEDURE
The enzyme solution (20ul) was added to a 0.5ml solution 
containing 5uM L-glutamyl-p-nitroaniline and 110 uM glycylglycine 
and the mixture incubated for 2 0 min. at 37°C. After which 2ml 
of a 10% (v/v) acetic acid solution was added to stop the enzyme 
reaction. The following reagents were all added in timed 
sequence. Sodium nitrite 1ml of a lmg/ml solution and then 1ml of 
a 1% (w/v) ammonium sulfamate solution. After three min. 1ml of 
2M naphthylethylenediamine solution was added to each tube. The 
resulting azo dye is measured at 54 0nm and the enzyme activity 
was calculated with reference to the standard curve (prepared 
using the diazo compound).
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beta-D-Galactosidase (GALACT.)
The activities of these enzymes was followed by monitoring the 
increase in absorbance of free methoxy-4-(2'-nitrovinyl)-phenyl 
(MNP) liberated from the substrate 2-methoxy-4-(2-nitrovinyl)- 
phenyl-2-acetamido-2-deoxy-beta-D-glucopyranoside (MNP-NAG) for 
N-acetyl-beta-glucosminidase, 2-methoxy-4-(2-nitrovinyl)-phenyl- 
B-D-galactoside (MNP-GAL) for B-D-Glactosidase and 2-methoxy-4- 
(2-nitrovinyl)-phenyl-glucopyranoside for glucosidase. MNP 
generation was followed spectrophotometrically by absorption at 
505nm and reference to a standard curve.
STANDARD CURVE PREPARATION
Various dilutions of a stock ImM solution of MNP in 96% ethanol 
(stable for one month at -2 0°C when stored in a dark bottle) were 
made in distilled water (final volume 1.1ml). To this was added 
0.5ml of buffer A and 0.5ml of buffer B, and the absorbance at 
505nm was then recorded.
BUFFER A is a 0.15 M citric acid/disodium hydrogen phosphate pH
4.5 for NAG and GLACT. (the optimum pH for these enzyme) and pH
5.5 for glucosidase.
BUFFER B is a 0.5 M sodium carbonate/bicarbonate pH 10.0, the 
addition of this to the reaction mixture rendered the enzyme 
inactive.
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Substrates were obtained from Dr.R.Price, University of London, 
London. U.K. MNP-N-acetylglucosamine:- The solid substrate 
(3 0mg) was added to the required volume of boiling water stirred 
for 1-2 minutes and then cooled by placing on ice. The resulting 
saturated solution was filtered through a Whatman's No.l filter 
paper.
MNP-Galactose and MNP-Glucose:- The solid substrate (42.8mg) was 
dissolved in 50ml of warm (60-70°C) distilled water. The 
resulting solution (2.4mM) was cooled on ice.
PROCEDURE
The test sample (0.1ml) was incubated with 0.5ml of buffer A and 
1.0ml of the appropriate substrate at 37°C for 30 min. The 
reaction was stopped with 0.5ml of buffer B and the amount of MNP 
liberated was assessed by it's absorbance at 505nm. The enzyme 
activity was calculated as follows.
ENZYME ACTIVITY
One unit of enzyme generates luMol of MNP per hour per litre of
reaction mixture.
Activity (U/l) = *(0.D) x C x 6 0 x  1000
(0.D)s x t x V
*(0.D) = Difference between test and blank
(O.D)s = Optical Density of standard (50nmol/l MNP)
C = Concentration of standard MNP (50nmol/l MNP)
t = Incubation time (hours)
V = Volume of test solution (1 x 10-41)
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2.6.1.Lowry Method
The reaction depends on the co-ordination of cupric ions with 
unshared electron pairs of peptide nitrogen and the oxygen atoms 
of water molecules to form a coloured co-ordination complex.
REAGENTS
A. 1% CuS04 (aq) (0.5g/50ml distilled water)
B. 2% Na/K Tartrate (lg/50ml distilled water)
C. 4% Na2 C03 0.1M NaOH
(4g NaOH + 40g Na2C03/l distilled water)
Folin-Ciocalteu's phenol reagent (2N solution)
PROCEDURE
A standard curve was prepared using bovine serum albumin (BSA) 
within the range 0 - lOOug/ml. The dissolved protein solution 
(lOOul) was added to 400ul of distilled water. To this was added 
2.5ml of the Cu-tartrate reagent (1ml A : 1ml B : 50ml C) and 
allowed to stand for at least 10 minutes. After this 0.25 ml of 
a 1:2 diluted (in distilled water) Folin-Ciocalteu's reagent was 
added and mixed immediately. The mixture was allowed to react 
for exactly 30 min. and the resulting blue colour was measured at 
720 nm.
2.6.2.Coomassie Method.
The method was that outlined by Read and Northcote, 1981. The 
reagents were prepared as follows; lOOmg of Coomassie Brilliant 
Blue G. (Sigma chemical co., Poole) was dissolved in 46.7ml of
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acid. The mixture was made up to 1 litre with distilled water and 
filtered through Whatmans No.l filter paper.
The procedure was as follows:- 0.2 ml of the test solution was 
aliquoted and 3.8 ml of the reagent (prepared as above) was 
added. The mixture was allowed to react for 10 minutes at room 
temperature and the absorbance at 595nm was recorded.
Protein concentration was assessed by relating to a standard 
curve prepared using bovine serum albumin. The relationship 
between absorbance at 595nm and protein concentration was linear 
up to 300 ug/ml and test solutions that were of greater 
concentrations were diluted before assessment.
2.7.INCORPORATION OF RADIOLABELLED PRECURSORS.
AMINO ACIDS USED SOURCE
SP.ACTIVITY
3H-proline Amersham - England
109Ci/mmol
3H-Lysine " »
40Ci/mmol
3H-Histidine " "
60Ci/mmol
3 5S -Cy ste ine 11 "
52.5mCi/mmol
3H-Thymidine " "
41Ci/mmol
The glomerular suspension (1ml in Tyrode's solution) containing 
the appropriate concentration of the relevant toxin was incubated 
with the diluted precursor (final concentration luCi/ml) for four 
hours at 37°C. The reaction was stopped by the addition of 3ml
DETAILS
Batch 38 
11 5 5
11 6 3
Lot 7 
Lot 79
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amino acid at ImM.
The precipitated glomeruli were then centrifuged at 250xg for 3 
min., the supernatant discarded and the pellet resuspended in 3 
ml of TCA. This washing procedure was repeated a further 3 
times to remove unbound amino acids.
The glomerular precipitate was then harvested on glass fibre 
filters (P100, Nucleopore Corp., Pleasanton, Califonia), and 
washed with 2ml absolute alcohol followed by 0.5ml diethyl ether. 
The filters with the precipitated glomeruli were each placed in 
a scintillation vial and 200ul of 0.5M NaOH added. The protein 
was allowed to dissolve for at least 2 hours and then 4.5ml of a 
"universal" commercial scintillant (Picofluor, Packard, Downers 
Grove, Illinois) was added, and the radioactivity present 
assessed using a LKB-Rackbeta scintillation counter.
To calculate the incorporation of precursors the endogenous 
concentrations of these were assumed to be minimal and the 
dilution of the added radiolabled precursor was regarded as being 
insignificant.
2.8. Isolation of Glomerular Basement Membranes.
The method was basically that of Lubec et al,1980. The isolated 
glomeruli were collected and washed in 0.85mg/100ml sodium 
chloride (3ml). This suspension was soni c a t e d  using an 
Ultrasonics sonicator (type 4522) with a 0.25 inch probe. 
Sonication was carried out at 3 0 second intervals for a period of 
1 min. each time. This procedure was repeated five times. The GBM 
was centrifuged at 2 000 x g for 10 min. at 4 C. The supernatant
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chloride at room temperature.. The later step is repeated 3 
times. The GBM preparation was examined by phase contrast 
microscopy to ensure purity from cells or undisrupted glomeruli.
2.9. Assessment of pentose phosphate pathway activity.
The method used was that of Rose et al 1976. The rate of glucose 
metabolism was assessed by trapping in KOH the carbon dioxide 
evolved from the metabolism of either Cl or C6 labelled (14C) 
glucose.
The procedure was as follows; 0.5ml of the glomerular suspension 
was added to a 0.5ml solution containing the test compound, 
Tyrodes buffer (bicarbonate was replaced with 6.7g/L HEPES) and 
0.4uCi of either Cl or C6 labelled glucose. The reaction mixture 
was placed in a flat bottom conical flask with a centre well. KOH 
(200ul of a 20% w/v solution) was added to the centre well with a 
small strip of fluted hard filter paper (Whatman 542) . The flask 
was then incubated in a shaking water bath at 37° C for 4 hr.
At the end of this incubation period the filter paper and KOH 
were removed and placed in a scintillation vial. The centre well 
was then washed 4 times with 200ul of 20% KOH. The KOH containing 
the trapped carbon dioxide was transferred to the scintillation 
vial, Scintillation fluid added and the radioactivity measured in 
a liguid scintillation spectrometer.
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3.1. Viability studies of isolated rat glomeruli
The assessment of viability was carried out as matter of routine 
and only glomeruli assessed to be more than 85% viable were used 
for further experimentation.
This was carried out by the examination of a glomerular 
suspension (in the presence of ethidium bromide and fluorescein 
diacetate) viewed under fluorescent lighting (390-490nm 
excitation and 510-515 emission filters were used). Individual 
cells on the surface of the glomeruli can be seen as either red 
or green. The green cells possess a cellular membrane that is 
impermeable to ethidium bromide (EB) and can be regarded as being 
viable whereas the red cells allow EB to enter and are regarded 
as being non-viable.
This method was used extensively because of the speed and ease 
with which the procedure could be carried out. This method also 
has the advantage that the extent of contamination with tubular 
fragments could be assessed at the same time.
To demonstrate that glomeruli were viable for a considerable 
period after isolation, indicators of glomerular viability such 
as ATP content, enzyme leakage, protein synthetic ability and 
pentose phosphate pathway activity were assessed.
The ATP content after 4 hr of incubation is not significantly 
different from that at the start (Fig. 3) . There was also no 
significant increase in the leakage of NAG, GALACT, and GLUC into 
the media on incubation for 4 hour at 37° C in Tyrodes solution 
(Fig. 4). This was also the case for LDH (Fig. 5).
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Figure 4.
The leakage of NAG, b e t a - D - g a l a c t o s i d a s e  and 
g l ucosidase from isolated rat glomeruli with 
time. Glomeruli were incubated in T y r o d e 1 s 
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of mean. The total enzyme activity found on 
sonication was:- NAG 63 +/- 3.0 U/mg protein,
b e t a - D - g a l a c t o s i d a s e  55.3 +/- 2.4 U/mg protein, 
glucosidase 48.8 +/- 3.6 U/mg protein.
48
Time in hours
Figure 5.
Leakage of LDH from control glomeruli with time. 
Bars represent standard error of mean (n=3).
No stastistical differences between measurement at 
at 1, 2, 3 and 4 hours.
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over 4 hours under the specified conditions. This was further 
corroborated by the presence of active biochemical processes over 
this period. For example protein synthesis (as measured by amino 
acid incorporation) was linear with time for at least 4 hours 
(Fig.6). Similarly pentose phosphate activity (Fig. 7) and 
thymidine incorporation representing DNA synthesis (Fig. 6) were 
shown to be active for at least 4 hours.
3.2. Enzyme leakage studies on isolated rat glomeruli.
No significant increase in the leakage of N-acetyl-beta-D- 
Glucosaminidase (NAG) , beta-D-Galactosidase (GALAC) , or 
Glucosidase (GLUC) from rat glomeruli was seen in the media over 
a 4 hour period (Fig. 4). LDH leakage with time was also minimal 
(Fig. 5) Glomeruli sonicated at the end of this period contained 
at least 5 times the enzyme activity present in the media (Fig. 
4), indicating that there was a releasable enzyme store. It can 
therefore be deduced that the cell integrity is well preserved 
over 4 hours. A 2 hour incubation period was chosen to study the 
effect of toxic compounds on enzyme leakage. As the glomerular 
cells maintain their.integrity for a considerably greater period 
this should minimise non-specific time dependent damage which 
would complicate the interpretation of data.
The effect of a number of compounds on the leakage of NAG at 
various concentrations is shown in Fig. 8. It can be seen that 
bromopropanamine (BPA) has no effect on NAG activity even at 
concentrations as high as 115mM.
50
UJ 1— o
DC
O -
CCc
DC
UJ
o
CD
cn
<C
DCO
O .
DCOO
DC O  - (/) d; DD O  
UJ 
DC 
Q -
to
UJ
OO
0.5 -
0.4 .
0.3 "
0.2
0.1 -
0 J
PR0LINE
•-- © HISTIDINE
LYSINE 
THYMIDINEEB B
TIME IN HOURS
Figure 6.
Incorporation of radiolabelled prec u r s o r s  into 
rat isolated glomeruli with time. Glomeruli were
incubated at 37 C in 
represent standard error
Tyrode's solution, 
of mean n=3.
Bars
51
c 5000 
a)•H
-p
o
u
ft
u
ctf
I—1
3
u<1)
&
o
r—I
to
to 2500 
6
# ---
•H
e
s
ft
p
Time in hours
Cl-Glucose
O — “ O  C6-Glucose
Figure 7.
Liberation of radiolablled carbon dioxide from 
the metabolism of Cl- or C6- labelled glucose by 
isolated rat glomeruli. D e m o n strating the 
stimulation of the pentose phosphate pathway. n=2
52
u/
mg
 
PR
OT
EI
N
160
120
80
40
0
STREPTOMYCIN
POLYBRENE
BEA
FEA
Pu.A
BPA
r—
50 100 150
CONCENTRATION (m MOLAR)
200
Figure 8.
The effect of a number of compounds on N-acetyl- 
beta-D-glucosaminidase leakage from isolated rat 
glomeruli after incubation for 2 hours. Bars 
represent standard error of mean. * =P<0.01; **
P=<0.005; *** P=<0.0005 n=4
53
activity and this reduction was concentration dependent in the 
case of streptomycin. Polybrene and flouroethanamine (FEA) both 
produce an increase in NAG activity. Puromycin aminonucleoside 
(Pu.A) below 5 mM reduces enzyme activity but enhances at higher 
concentrations.
To determine if these compounds could affect the activity of the 
free enzymes, as well as their release from glomeruli, the 
effects of the above mentioned compounds on NAG activity were 
studied on whole kidney homogenate (Fig. 9) . It can be seen that 
BEA and streptomycin both reduced the activity. This reduction is 
concentration dependent and statistically significant in both 
cases. Polybrene produced a significant increases in NAG activity 
at concentrations as low as 0.35mM. This was concentration 
dependent and was as high as 150% of control at a concentration 
of 5.3mM. Pu.A, generally, had little effect on NAG activity.
The leakage of gamma glutamyl transpeptidase (GGT) from rat 
glomeruli in response to incubation with toxic compounds is shown 
in Fig. 10. Streptomycin at lOmM and BEA at 20mM both produce a 
reduction of enzyme activity. The effects of polybrene, BPA, FEA, 
and Pu.A are not statistically different from control, except at 
a concentration of 42mM when Pu.A produces a significant 
reduction. None of these compounds reduce GGT activity in whole 
kidney homogenate (Fig. 11) suggesting that these compounds did 
not have a direct interaction with the enzyme or its assay.
GALAC activity in rat glomeruli is significantly increased by BPA 
at concentrations above 29mM (Fig. 12).
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streptomycin have no effect at concentrations below 50mM. In rat 
whole kidney homogenate BEA, Pu.A and streptomycin reduce GALAC 
activity but polybrene has no effect (Fig. 13).
The activity of alkaline phosphatase (Alk.Phos.) from rat 
glomeruli is reduced by all the compounds studied but at higher 
concentrations polybrene produce an increased activity in 
relation to untreated controls (Fig. 14) . In the rat kidney 
homogenate BEA, Pu.A and streptomycin inhibit the Alk.Phos. 
activity (Fig. 15).
The leakage (as assessed by activity in the incubation media) of 
lactate dehydrogenase (LDH) from isolated rat glomeruli is 
increased by polybrene and reduced by BEA and Pu.A BPA and FEA 
increased activity only at very high concentrations (Fig. 16). 
Figure 17. shows the effects of these compounds on LDH activity 
in rat kidney homogenate. It can be seen that BEA and 
Streptomycin significantly reduce LDH activity while other 
compounds have little effect. Fig. 18. shows an absorbance 
spectra for adriamycin at various concentrations up to 50uM. Due 
to the intense absorbance by adriamycin at the wavelengths used 
for the spectrophotometric assays of NAG, GALACT, GLUC, GGT, and 
Aik. Phos. It was deduced that the assay procedure for these 
enzymes could not be carried out in the presence of adriamycin 
(ADR) without significant interference by ADR itself. This 
severly restricted the usefulness of these enzymes as markers of 
glomerular damage.
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This enzyme leakage is time and concentration dependent (Fig. 
19). A small amount of LDH leakage is seen at ADR concentrations 
of 0.5mM, increasing dramatically at ImM.
The enzyme contents of rat isolated glomeruli and whole kidney 
homogenate is shown in Fig. 20. It can be seen that glomeruli 
contain greater quantities of LDH than whole kidney homogenate on 
a milligram protein basis. The homogenate contains greater 
amounts of Aik. Phos. and gGT whereas NAG activity was similar 
in both. GALAC activity, although greater in glomeruli, it was 
not very high in either.
3.3 Protein synthesis in isolated rat glomeruli.
The incorporation of tritiated proline into glomerular protein in 
the presence and absence of 0.5mM unlabelled proline is shown in 
Fig. 21. This incorporation is time dependent in both cases, 
however it is much greater in the absence of unlabelled proline. 
In consideration of the small amount (0.2-0.4mg protein) of 
tissue in the reaction mixture and the relatively small amount 
incorporated in relation to the total added, cold carrier amino 
acids were not used in the remaining experiments.
The time course of incorporation of radiolabelled proline, 
histidine and lysine into isolated rat glomeruli is shown in Fig. 
5. The incorporation of these amino acids was linear with time 
over 4 hr. The extent of incorporation was lysine > proline > 
histidine. Polybrene at concentrations as low as O.lmM produced 
greater than 95% inhibition of proline incorporation into rat 
glomerular protein (Fig. 22).
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protein appeared to be little affected by polybrene even at 
concentrations of ImM (Fig. 22). Histidine incorporation was 
markedly affected by 0.25mM polybrene.
ADR inhibited the incorporation of proline and histidine but not 
lysine (Fig. 23). The potency of this inhibition was as follows; 
proline > histidine > lysine. Pharmarubicin a structural analogue 
of ADR did not differ in its potency with respect to the 
inhibition of proline incorporation (Figure.24). Streptomycin 
significantly inhibited the incorporation of proline in a 
concentration dependent manner (up to 14 mM) Fig. 25. Pu.A 
inhibits the incorporation of proline by 50 % of control at a 
concentration of 10 mM (Fig. 26).
The h a l o a l k y l a m i n e s  BEA and BPA both inhibit proline  
incorporation (Fig. 27 and 28) in a concentration dependent 
manner. BEA, below 50mM, is a more potent inhibitor of proline 
incorporation than BPA (Fig. 29). Fig. 28 shows that BEA also 
inhibits lysine incorporation into isolated rat glomeruli.
The cysteine conjugate of hexachlorobutadiene does not reduce the 
incorporation of proline into glomerular p r o t e i n  at 
concentrations below 2 mM (Fig. 30). At this concentration the 
incorporation of proline into rat kidney tubular fragments is 
inhibited by 66 % (Bach et al, 1986) ADR has been shown to 
produce its caridotoxicity by redox cycling and the generation of 
oxygen free radicals (Llesuy et al, 1985) . To investigate this 
further, the herbicide, paraquat which is known to produce its 
toxic effects by a free radical mediated mechanism was examined 
in this system.
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The effect of Adriamycin on r a d i o l a b e l l e d  
precu r s o r  incorporation into rat isolated 
glomeruli after 4 hours incubation. Bars 
represent standard deviation from mean * 
P<0.0005. n=3
72
PI
CO
MO
LE
S 
PR
OL
IN
E 
IN
CO
RP
OR
AT
ED
/m
g 
GL
OM
ER
UL
AR
 
PR
OT
EI
N 0.4
0.3
0.2
0.1
0
O-- o ADRIAMYCIN
* ____ O  PHARMARUBICIN
0.1
— i i
0.2 0.25
CONCENTRATION (m MOLAR)
Figure 24.
A comparison 
phamarubicin 
incorporation
of the effects of a r iamycin and 
on r adiolabelled proline 
into rat isolated glomeruli. Bars 
represent standard deviation from mean. No 
statistical differences between pharmarubicin and 
Compared to control all pointsadriamycin
significant.
n=3
P<0.005, except *= not significant.
73
PI
CO
MO
LE
S 
PR
EC
UR
SO
R 
IN
CO
RP
OR
AT
ED
/m
g 
GL
OM
ER
UL
AR
 
PR
OT
EI
N
o O PROLINE
H B THYMIDINE
Q *
0
i— —  -----------1-------------- 1 ; «
. 0 5 10 15
STREPTOMYCIN (m MOLES)
Figure 25.
The effect of Streptomycin sulphate on 
r adio l a b e l l e d  precursor i n c o r poration into rat 
isolated glomeruli after 4 hours incubation. Bars 
represent standard deviation from mean 
*=P<0.0005. n=3
74
0.5.
0.4-
0.1
LUf—O
OC
O-
OC<
o
_ !
CD
CD
E
lo.ao o
o: 
o
GOo'=> o
UJ* 0.14
CO
UJ
O PROLINE 
.. THYMIDINE
Q
oo
QJ
i---------1---------1---------1--------1---------1
0 2 4 6 8 10
PUR0MYCIN AMIN0NUCLE0SIDE (m MOLAR)
Figure 26.
The effect of Puromycin Aminonucleoside on r a d i o ­
labelled precursor incorporation into rat 
isolated glomeruli after 4 hours incubation. Ba 
represent standard deviation from mean ** P<0.0 
*** P<0.0005. n=3
75
o
occ
D _
CC<c
cc
UJz:o
_Jo
cr-
o
D _
Oo
OfOOO
CC
ZDo
UJa:a.
c/)
UJ
oo
0.4
0.3
0.2
0.1 -
PROLINE
B  THYMIDINE
6 *
50
BR0M0ETHANAMINE CONCENTRATION 
( m MOLAR)
100
Ficrure 27.
The effect of B r o i o e thanamine on r a d i o l a b e l l e d  
precu r s o r  incorporation into rat isolated 
glomeruli after 4 hours incubation. Bars 
represent standard deviation from mean *=P<0.0005. 
n=3
76
2? 
*— i
LlJI—
0.5-oDC
Cl.
oc<
_ j
Sio
_ Jo 0.4_ 0-- O PROLINE
□--D LYSINE
H H  THYMIDINE
o
UJI—
<cc
oa.
DC O O 2: 
t—1
o
UJO'O.
0.2-co
UJ
_ lo
s:oo
t— I
a .
1 1 1
. 0  50 100
BR0M0PR0PANAMINE(m MOLES)
Figure 28.
The effect of B r o m opropanamine on r a d i o l a b e l l e d  
precursor incorporation into rat isolated 
glomeruli after 4 hours incubation. Bars 
represent standard deviation from mean *=P<0.0005. 
n=4
77
0.5
occ
Cl.
CC
c
cc
UJ2:0
—I
CD
01
2oa.
ccoo
UJ
occ
a .
00
UJ
oo
0.4
0.3
0.2
0.1
0
BR0M0ETHANAMINE
O BR0M0PR0PANAMINE
Tr T
0 50 100
CONCENTRATIONmMOLES
Figure 29.
A comparison of the effects of B r o m o e t h a n a m i n e  
and B r o m o p r opanamine on r a d i o l a b e l l e d  proline 
incorporation into rat isolated glomeruli. Bars 
represent standard deviation from mean * P<0.0005. 
n=4
78
occ
Cl.
CC<
o
CD
cn
<
DCO
o _cc
oo
occ
C l.
CO
UJ
oo
4
a
0 . 1-
— I 
10
HCBD-CYSTEINE ( m MOLAR )
Figure 30.
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proline incorporation into rat isolated glomeruli 
after 4 hours incubation. Bars represent standard 
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concentrations below 0.5mM (Fig. 31). At a concentration of 1.0 
mM inhibition is 50% of control.
At ADR concentration that have no effect on the ATP content of 
glomeruli or the leakage of LDH proline incorporation is markedly 
inhibited (Fig. 32). This suggests that the inhibition of proline 
incorporation is the most sensitive indicator of ADR-induced 
glomerular damage. From morphological studies (Fishman and 
Karnovsky, 1985) it has been shown that the glomerular basement 
membrane (GBM) changes in thickness in response to various toxins 
and disease states. The major protein component of GBM is type IV 
collagen. This is also the major molecule for the incorporation 
of proline. To investigate to what extent amino acid 
incorporation into isolated rat glomeruli was due to synthesis of 
GBM components, the GBM was isolated and the extent of 
incorporation established. Figure 33. shows that 70 % of lysine, 
14.5 % of histidine and 55 % of proline incorporation into 
isolated rat glomeruli is incorporated into the GBM.
3.4 DNA synthesis in isolated rat glomeruli.
From the above it can be seen that ADR considerably inhibits 
protein synthesis. It is well established that ADR intercalates 
with DNA (Lenaz and Page, 1976) as part of its toxic effect on 
neoplastic cells. To establish whether DNA or protein synthesis 
were the initial targets, the effects of ADR and other compounds 
on DNA were investigated. The synthesis of DNA by isolated rat 
glomeruli was followed by the incorporation of tritiated 
thymidine.
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thymidine over 4 hr (Fig. 6). This incorporation is inhibited by 
ADR but at concentrations greater than those required to effect 
proline incorporation (Fig. 23). Polybrene at a concentration of 
0.5mM (Fig. 22) inhibits thymidine incorporation. This was at 
higher concentrations than required to inhibit proline. 
Furthermore this inhibition never exceeded 50% of control. BEA 
and BPA only inhibit thymidine incorporation at concentrations 
above 50mM (Figs. 27 and 28). Streptomycin does not significantly 
affect thymidine incorporation at concentrations up to 15 mM 
(Fig. 25).
3. 5. Protein synthesis in isolated pig glomeruli.
To see if glomeruli isolated from another species could maintain
their viability and biochemical capacity, pig glomeruli were
isolated (as described). Protein and DNA synthesis with time in
the presence and absence of toxins was investigated. The
incorporation of tritiated proline into pig glomeruli is linear
for up to 8 hours (Fig. 34). However, the incorporation was to a
lesser extent than in rat glomeruli (Fig. 20). The effect of
BEA, BPA and FEA over 4 hours is shown in Fig. 35. BEA reduces
proline incorporation to the greatest extent in this series of
analogs. FEA and BPA are similar in their potency of inhibition.
This was also the case for rat glomeruli (Figs. 27 and 28).
Polybrene inhibited the incorporation of proline into pig
glomerular protein to the greatest extent. ADR was not examined.
Although polybrene significantly reduced proline incorporation
into isolated pig glomeruli, this inhibiton never exceded 50% of 
the total.
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the incorporation of proline. (Fig. 36).
3.6. DNA synthesis in isolated pig glomeruli.
Figure.34. shows that there is a significant incorporation of 
tritiated thymidine over an 8 hour period. This, again, was less 
than into rat glomeruli. The haloalkylamine series BEA, BPA and 
FEA have very little effect on DNA synthesis over 4 hours (Fig. 
37). Only BPA produces a significant increase in tritiated 
thymidine incorporation at a concentration of 29 mM but this 
incorporation is unaffected at higher concentrations (57mM). 
Polybrene significantly reduces DNA synthesis at concentrations 
above 1 mM (Fig. 38). In the same figure it will be seen that 
both streptomycin and HCBD-cysteine increase DNA synthesis but 
this is not statistically significant for streptomycin and only 
significant for HCBD-cysteine at a concentration of 4mM.
3.7.The effect of free radical scavengers on adriamycin induced 
inhibition of protein synthesis in isolated rat glomeruli.
ADR has been shown to induce at least part of its cardiotoxic 
effect by the production of free radicals. To investigate whether 
this was the mechanism (or part of the mechanism) by which ADR 
inhibited protein synthesis in isolated glomeruli, the effect of 
a number of free radical scavengers on proline incorporation was 
studied. It can be seen from Fig. 39. that only mannitol 
significantly affects the inhibition of tritiated proline 
incorporation by adriamycin. Superoxide dismutase (SOD) which 
does not affect the adriamycin inhibition significantly.
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glomeruli (Fig. 39). Histidine on its own reduced the 
incorporation of tritiated proline although this effect is not 
additive to that of adriamycin when the two were combined.
3.8.The effect of free radical scavengers on adriamycin induced 
inhibition of DNA synthesis in isolated rat glomeruli.
As with protein synthesis it was possible that ADR produced its 
DNA inhibitory effect by a free radical mediated mechanism. The 
effects of a number of radical scavengers was investigated. 
However no significant inhibition of the adriamycin effect was 
observed with any of the free radical scavengers used (Fig. 4 0) . 
It is however, interesting that incubation of the glomeruli with 
the free radical scavengers alone invariably produced a reduction 
in tritiated thymidine incorporation. This reduction is only 
statistically significant in the case of glutathione (GSH) (p< 
0.0005).
3.9.Pentose phosphate pathway (PPP) in isolated rat glomeruli.
The conversion of l“14C-glucose to radiolablled carbon dioxide 
was greater than the conversion of 6-14C-glucose to radiolablled 
carbon dioxide by isolated rat glomeruli (Figs.7&41). The ratio 
being 1.5:1, showing that the presence of the PPP in this tissue. 
The herbicide paraquat has been reported to stimulate this 
pathway in isolated lung slices (Rose et al, 1976) by redox 
cycling. To see whether paraquat could similarly affect isolated 
rat glomeruli it was selected for further investigation.
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PPP activity. ADR also produced a very similar concentration 
dependent increase in PPP activity (Fig. 42). To ascertain 
whether this stimulation was due to redox cycling the radical 
scavenger desferrioxime was added to the system in the presence 
and absence of ADR or paraquat. Desferrioxime reduced PPP 
activity for both ADR and paraquat to similar extent. It did 
however also reduce PPP activity in its own right (Fig. 43).
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4. DISCUSSION.
The glomerulus is the principle route by which a blood borne 
xenobiotic bound to low molecular weight protein or unbound may 
enter the nephron. It has the capacity to monitor and modify the 
effective renal (glomerular) filtration rate in response to many 
physiological changes. This involves the complex and dynamic 
interaction of the various glomerular cells. The glomerulus 
appears to be inert to many toxins which damage other parts of 
the kidney, yet some such as adriamycin and p u r o m y c i n  
aminonucleoside selectively damage the glomerulus, particularly 
the epitheial cells. The study of xenobiotics on the glomerulus 
is complicated in-vivo by the dynamics of the whole organism i.e 
uptake, metabolism, distribution, and other extraglomerular 
factors.
By contrast isolated glomeruli, although inherently limited, 
provide several advantages for studying this group of cells. A 
great deal of information can be obtained using only a small 
numbers of animals and several different parameters can be 
assessed from the same tissue, allowing comparison of data, while 
minimizing tissue variability. Isolated glomeruli allow the study 
of glomerular characteristics, or functions as well as metabolic 
properties, in a defined environment and independent of 
haemodynamic changes or other extraglomerular factors. The 
limitations of isolated glomeruli are, in part, inherent to most 
in-vitro systems. These include short viability, which restricts 
studies to acute effects following a toxic insult. Xenobiotics
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supply are in-vitro presented in the absence of previous 
metabolism, plasma protein binding and p h a r m a c o k i n e t i c  
distribution. These factors must be borne in mind when 
extrapolating data from in-vitro glomerular studies, i.e. in- 
vitro studies assess glomerular c y t o toxicity and not 
nephrotoxicity per se.
4.1 Enzvme leakage studies on isolated rat glomeruli.
The use of enzyme leakage as a simple and rapid indicator of 
cellular damage is well established in both experimental 
(Sobrinho-Simoes et al, 1977) and clinical use (Elleder and 
Stejskal 1985). Indeed the urinary profiles of the enzymes NAG, 
LDH and GGT have been used as indicators of an adriamycin induced 
nephrosis (Thomsen et al, 1990). It was for this reason that 
enzyme leakage was chosen to assess xenobiotic induced toxicity 
in these in-vitro studies. Surprisingly, some compounds increased 
enzyme activity greater than that by sonication (e.g. polybrene 
on NAG activity). With other compounds lower enzyme activity 
than the basal level was seen (e.g. streptomycin effect on NAG 
and GGT). These observations highlighted the possibility that 
compounds can have a.direct effect on enzyme activity as opposed 
to a cellular effect reflected by a change in enzyme activity. 
Many chemicals (e.g. heavy metals) inhibit enzymes. Glomeruli and 
renal homogenate were assessed to document any such effects.
Whole rat kidney homogenate was used as a rapid and economical 
source of the free enzymes. It was assumed that on homogenization 
the enzymes would be released from their cellular compartments 
into the medium. This did not represent a pure enzyme solution in
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constituents likely to affect its activity are present. These 
factors include: l)the presence of proteolytic enzymes, 2) other 
enzymes likely to compete for co-enzymes or co-factors of the 
enzyme to be studied, and 3) the presence of activator or 
inhibitor molecules (e.g. metal ions such as copper and zinc). 
These factors represent a serious drawback if the effect of the 
compound on the pure enzyme were to be the objective. If this was 
to be the case it may have been better to assess the effects on 
commercially available enzyme preparations. These also have their 
drawbacks in that the enzyme is likely to have been isolated from 
an organ and/or species other than that of interest. Indeed even 
if the enzyme was isolated from the same organ and species there 
can still be differences in response due to the fact that 
different isoenzymes have been reported in differant parts of the 
same nephron (Taylor et al, 1971). This would mean that there are 
likely to be differences in response between rat glomerular 
enzymes and commercially available preparations. Therefore, for 
our purposes, rat kidney homogenate was considered to be more 
appropriate than the pure enzymes.
A comparison of the effect of the compounds on isolated glomeruli 
and on kidney homogenate gave a truer indication as to the 
possible mechanism by which they induce changes in enzyme 
activity. The relationship between toxicity and glomerular 
release of enzymes is complex. It will be seen that a number of 
possible interactions between the xenobiotics and glomerular 
enzyme release exist. These are the addition of the xenobiotic:-
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in enzyme release from various cellular compartments.
II) in some way ’’stabilizes" the. glomerular cells and enzyme 
release is diminished.
III) causes glomerular damage which leads to enzyme release, but 
the enzyme activity is inhibited by the xenobiotic.
IV) enhances the activity of the enzymes released.
V) has its primary action on inhibiting enzyme activity.
These studies indicate that a number of compounds have 
interactions that seem to fit into these catagories. It will be 
seen that compounds had a different effect in relation to each 
enzyme. For example, BEA reduces the release of gGT and LDH from 
glomeruli, but, also inhibits GALACT. activity after release from 
glomeruli. The activities of NAG and Alk.Phos. are inhibited by 
BEA without any affect on glomerular release of these enzyme.
The five enzymes studied were situated in different cellular 
"compartments". Alkaline phosphatase and gGT are membrane bound, 
LDH is cytoplasmic, whereas the acid hydrolases NAG and GALACT. 
are both lysosomal. In theory, the extent of cellular damage 
should be reflected by the compartments damaged and the enzymes 
thus released. It would therefore be reasonable to expect that 
the release of enzymes would be in a logical order reflecting the 
organelle damaged.
In these studies such a relationship is not apparent. NAG and 
GALACT are both lysosomal so it would be expected that the 
release of each enzyme would be accompanied by the other. This 
was not the case, for example FEA causes NAG release but not 
GALACT, BPA causes GALACT. release but not NAG. These
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compounds with the enzymes.
At concentrations of BPA and FEA that cause lysosomal enzyme 
release there is LDH release but only small amounts of gGT and no 
Alk.Phos. release. This lack of activity may be due to the fact 
that these enzymes are present only in low concentrations in the 
rat glomerulus.
Polybrene induced a large LDH release but not of the other 
enzymes. This again may be due to the low concentration of gGT 
and Alk.Phos., but the lack of lysosomal enzymes cannot be 
explained readily.
All the compounds studied inhibit enzyme activity, except 
polybrene which enhanced NAG, ALK.Phos activity. Polybrene is a 
highly charged polycationic polymer that has characteristics 
associated with detergents. It is therefore possible that NAG 
activity is enhanced by polybrene dissolving membranes and 
liberating NAG. Similarly Alk.Phos. activity may be enhanced by 
polybrene liberating or exposing the membrane bound enzyme. This 
detergent effect may also be the mechanism by which LDH is 
released from the glomeruli.
BEA and its structural analogs BPA and FEA would be expected to 
show some trends in their effects on glomerular enzyme release or 
inhibition. One of the more striking features of this series of 
molecules is the varying degree of ease with which they lose the 
halogen moeity. The flourine atom of FEA does not readily 
dissociate, the bromine atom of BEA dissociates more readily and 
the bromine atom of BPA is most easily lost due to the greater
ability does not however relate readily to the release or 
inhibition of enzymes from the glomerulus. For example BEA 
inhibits NAG release, FEA enhances NAG release, and BPA does not 
affect NAG activity. This lack of relationship by this series of 
analogs is also displayed by the other enzymes studied. 
Streptomycin reduced the activities of most of the enzymes 
studied. In the case of NAG this reduction can be explained by 
direct action on the enzyme. This can be deduced from the fact 
that streptomycin reduced the activty of NAG in whole kidney 
homogenate. In other cases, where no effect on enzyme activity is 
seen the released enzyme may be inhibited by streptomycin e.g. 
in the case of GALACT. and LDH.
P u .A induces the release of NAG from glomeruli, this is 
consistent with the observations of Velosa et al, (1980). who 
have reported that Pu.A-induced nephrosis results in reduced 
glomerular content of NAG and an increased instability of 
lysosomes. This observation was however contradicted by the 
effect of Pu.A on the other lysosomal enzyme GALACT, the activity 
of which was reduced. This reduction was readily explained by the 
observation that Pu.A inhibits GALACT. activity in the kidney 
homogenate. The enzyme is particularly sensitive to inhibition by 
substrate analogues. It is possible that this inhibition was due 
to an association of the enzyme with the sugar moeity of the Pu.A 
molecule. The activities of LDH and Alk.Phos. are also inhibited 
by Pu.A. This inhibition is unlikely to be due to a substrate 
analogues effect. The assessment of adriamycin induced leakage 
was further complicated by the intense absorption of adriamycin
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activity for NAG, GALACT, GGT and ALK.PHOS.
Adriamycin produces a concentration dependent increase in LDH 
leakage which indicates that LDH may be useful as an indicator of 
adriamycin induced glomerular damage. However this enzyme leakage 
occurred at concentration higher than those required for 
perturbation of other biochemical parameters.
A comparison of enzyme activity in sonicated glomeruli and whole 
rat kidney homogenate demonstrated the specific activity of 
glomerular LDH was greater than that of the other enzymes 
studied. This is consistent with the observation of Guder and 
Ross 1984, who reported that the LDH content of glomeruli is 
greater than that of the acid hydrolases NAG and GALACT. Indeed, 
Taylor et al,(1971), have demonstrated that the specific activity 
of NAG and GALACT. were similar in rat isolated glomeruli and 
homogenate. This would suggest that of the enzymes studied, LDH 
was the most appropriate.
Enzyme activity has, in this study been measured as an indicator 
of the presence of enzymes released in response to toxic insult. 
It can be seen from the data presented that a simplistic 
relationship of this type did not exist. A simpler system may 
have been to study the release of a "marker" that is easier to 
quantify. A system such as this has been described by (Thelstam 
and Mollby, 1980), using leakage of radiolabled macromolecules of 
differant molecular weights in a tissue culture preparation.
In conclusion, the assessment of enzyme leakage to study toxicity 
in isolated rat glomeruli is fraught with difficulty. It is
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bisphoshate aldolase or adenylate kinase which are reported 
(Burch et al, 1980? Cole et al, 1982) to be in significantly 
higher concentrations in the rat glomerulus, may have produced 
more cohesive data. The results could still be complicated by 
direct interaction of the compounds to be studied with the 
enzymes or the assay procedures. Other factors that are likely to 
make interpretation of enzyme leakage data difficult include the 
fact that rat glomeruli contain relatively high concentrations of 
enzymes with protease activities (Sudo, 1981) . This means that 
the proteases released at the same time as the measured enzymes 
would degrade (and therefore reduce the activity of) these 
enzymes. Therefore, the enzymes showing most activity would be 
those which are least susceptible to proteolytic damage. Thus 
enzyme activity is not a reliable indicator of cellular damage in 
isolated glomeruli.
4.2 Radiolabelled precursor studies in rat glomeruli.
The incorporation of precursors has been represented as 
picomol/mg golmerular protein. These calculations required the 
assumption that the "endogenous pools" of these precursors were 
minimal and the resulting dilution to the radiolabelled 
precursors added was insignificant. The basis for this assumption 
is that the radiolabelled precursors were added in several orders 
of magnitude greater than the likely pool sizes.
It is clear from these studies that isolated rat glomeruli are 
viable and biochemically active for at least 4 hours. This is 
consistent with the observations of others who have isolated
105
Meezan 1973, Cohen and Voght 1974, Grant et al, 1975). For 
example, (Brendel and Meezan, 1973) have demonstrated that 
glomeruli isolated from rats using magnetic iron oxide are 
capable of metabolising a considerable number of substrates of 
both the glycolytic and Krebs pathways, including glucose. This 
is consistent with observations reported in this thesis and by 
Delacruz 1988. The incorporation of the amino acids proline, 
lysine, and histidine was linear with time for at least 4 hours. 
This is consistent with findings of (Grant et al, 1975) who 
demonstrated linear incorporation of proline and lysine into 
glomeruli (isolated by a discontinues ficoll gradient) for 6 
hours. Krisko and Walker (1976) have reported lysine and proline 
incorporation to be linear for 8 hours. This is further supported 
by (Cohen and Voght, 1974) who report lysine incorporation to be 
linear for 2 hours. The studies reported in this thesis show 
that the incorporation of lysine is greater than of proline. This 
was in accord with the findings of (Grant et al,1975) and (Krisko 
and walker 1976) . However, (Price and Spiro, 1977), looking at 
GBM turnover in-vivo report that proline incorporation was 
greater than lysine. The study was however, over a long period of 
time (3 weeks). This suggests that the uptake of amino acids 
changes with time or that isolated glomeruli incorporate amino 
acids by a different method to the in-vivo situation.
The incorporation of histidine into glomeruli and its presence in 
the GBM was considerably less than either proline or lysine. This 
is of interest in that both proline and lysine are important
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(section 1.5). It is known that the GBM is affected 
biochemically, functionally and morphologically by toxic agents 
(Kanwar et al, 1980), Martino et al, (1986), Kriesberg et 
al,(1978). Other parameters such as mechanical pressure, as 
hypertension/hyperperfusion, have been reported to produce 
changes in the GBM (Ohishi et al,(1989).
The studies reported here show that a significant proportion of 
the amino acids proline and lysine incorporated can be isolated 
in the GBM (Fig. 3 0). Since the turnover of the GBM in-vivo has 
been estimated to be 100 days (Price and Spiro 1977), it is 
tempting to rationalise the relatively rapid incorporation of GBM 
amino acids, by speculating that the trauma of the isolation 
procedure in some way triggers the synthesis of GBM components. 
This incorporation of amino acids was affected by a number of the 
toxins, and proline was more sensitive than lysine. The reduction 
of proline incorporation was a more consistent and reliable 
indicator of glomerular toxicity than enzyme leakage. The 
concentrations of toxins required to produce a reduction in 
proline incorporation were consistently lower than those required 
to produce enzyme leakage, suggesting that this inhibition 
represents a selective toxic effect on isolated rat glomeruli. 
This was best demonstrated by the effect of the established 
glomerular toxin ADR (Long et al, 1984, Paschaud et al 1985, O 
Donnell et al 1985, Remmuzzi et al 1985, Bach et al 1986). ADR 
produced a marked inhibition of proline incorporation into rat 
isolated glomeruli in a concentration dependent manner at 
concentrations below ImM. The papillary toxins BEA and BPA
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apparent lack of toxicity of BEA and BPA, was also seen with the 
cysteine conjugate of HCBD which at concentrations of 2mM had no 
effect on glomerular proline incorporation. At this concentration 
HCBD-cysteine produced a 66% inhibition of proline into isolated 
rat proximal tubular fragments (Bach et al, 1986).
Streptomycin is known to inhibit protein synthesis, however, the 
concentrations required to affect proline incorporation into rat 
glomeruli is markedly greater than that required for adriamycin 
thus indicating the selective nature of the adriamycin effect. 
From work carried out in our laboratory (Ketley, C.P. unpublished 
data) it was shown that the potency with which polybrene inhibits 
amino acid incorporation into rat tubular fragments is the same 
as for glomeruli. This further strengthens the hypothesis that 
polybrene causes its toxicity by a non-specific (possibly 
detergent like) effect. Adriamycin reduced the incorporation of 
proline into rat tubular fragments, (Bach et al, 1986) but at 
higher concentrations (IC50 0.05mM for glomeruli compared to 
0.2mM for proximal tubules) than required for rat glomeruli, 
demonstrating that adriamycin has a selective action on 
glomeruli.
This selectivity is further supported by the fact that ADR has 
been shown to selectivly damage glomerular epithelial cells 
(Remmuzzi et al 1985, Bach et al, 1986, Ito et al, 1986, Soose et 
al, 1988). Studies in our laboratory using flouresence microscopy 
(Bach,et al, 1986) suggests that ADR is taken up by glomerular 
epithelial cells to a greater extent than into adjacent mesangial
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synthesize components of the glomerular basement membrane 
(Kriesberg et al, 1978).
It is therefore possible to postulate that glomerular epithelial 
cells synthesize a component of the GBM which is rich in proline 
and ADR selectively damages these cells thus reducing glomerular 
uptake of proline.
4.3 The possible role of free radicals in adriamycin-induced 
glomerular damage.
ADR is thought to produce at least some of its toxic effects by 
redox cycling and the generation of free radicals (Doroshow 1986, 
Abdella and Fisher 1985, Geetha et al., 1990). The glomerulus 
synthesizes arachidonic acid metabolites (Hassid et al., 1979). 
Prostaglandin H synthetase, the enzyme responsible for this, is 
able to use a large number of structurally diverse xenobiotics as 
reducing co-faCtors and the subsequent production of free 
radicals (Eling et al., 1983, Marnett and Eling, 1983). Thus, ADR 
may produce some of its effects on glomeruli by redox cycling, a 
mechanism already postulated by Lleusy et al., 1985, for ADR 
induced cardiotoxicity.
Adriamycin is metabolised to a semiquinone intermediate by NADPH- 
dependent mixed oxidases (Mimnaugh et al., 1986). High levels of 
these oxidase systems are present in the kidney cortex. In the 
presence of oxygen, the semiquinone radicals generate reactive 
oxygen species and create an oxyradical cascade resulting in 
lipid peroxidation. Peroxidation of the lipid changes the 
structure and function of plasma membranes resulting in
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The fact that redox cycling can produce gross damage in-vitro has 
been demonstrated by Tomasi et al, 1983. They reported a time 
dependent LDH leakage from isolated hepatocytes corresponding 
directly to the generation of halothane radicals. The studies 
presented in this thesis also demonstrate a time dependent LDH 
leakage from isolated rat glomeruli in response to incubation 
with ADR.
A number of studies using agents that sequester free radical 
species were carried .out. The results show that the incorporation 
of proline or thymidine is unaffected by these agents. This 
suggests that either the adriamycin mediated glomerular toxicity 
(as measured by proline inhibition) is not free radical mediated, 
or that the sequestering agents are unable to reach the site of 
free radical generation.
GSH is well known to have a protective role in-vivo by the 
removal of free radicals. Glutathione a known free radical
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glomerulus (Burke et al, 1976). However, the addition of 
exogenous GSH has not p r o t e c t e d  the glomeruli from ADR 
cytotoxicity.
Wilks, 1990 has also found that GSH does not protect glomeruli 
against heavy metal inhibition of proline uptake. Slater et al., 
(1976), have highlighted the problem of getting the free radical 
scavenger to the "right place at the right concentration and at 
the time". Some or all of these factors could play a role in the 
failure of free radical scavengers in the above investigations to 
reduce the cytotoxic effect of adriamycin. It is not clear 
whether these exogenous free radical scavengers are taken up by 
isolated glomeruli. If ADR was redox cycling in isolated 
glomeruli, the levels of intracellular reduced glutathione must 
be affected. This would need to be replenished (i.e converted 
from the oxidised form to the reduced f o r m ) , w h ich is 
predominantly the function of glutathione reductase and NADPH. 
NADPH is generated by the pentose phosphate pathway (PPP), 
stimulation of which can be representative of redox cycling. This 
is summarised below. The glomermular PPP is stimulated by 
adriamycin in these studies. The herbicide paraquat, which is 
known to redox cycle, also stimulated the PPP in isolated 
glomeruli in a concentration dependent manner (Fig. 33). 
Furthermore, the free radical scavenger desferrioxime partially 
blocks this stimulation of the PPP by ADR or paraquat. This would 
suggest that desferrioxime is able to get to the site of free 
radical generation of ADR and paraquat. Desferrioxime does
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right. This suggests that the process of isolating glomeruli 
leads to the activation of the PPP. Free radical scavengers also 
increase the incorporation of proline and reduce thymidine 
incorporation, further suggesting the involvement of damaging 
free radicals generated in the isolation procedure. This has been 
supported by the recent observations of Green et al (1990), who 
have reported the involvement of oxidative stress in damage to 
rat proximal tubules during isolation. They also found that this 
damage can be dr a m a t i c a l l y  reduced by the addition of 
desferrioxime. This further suggests that desferrioxime is able 
to prevent free radical mediated cytotoxicity in isolated kidney 
fragments.
Cl Glucose-6-P Ribulose-5-P------ ** PPP
+ CO
2 NADP 2 NADPH
2 GSH
0*-
The effect of SOD on glomerular incorporation of proline is 
interesting in that a marked increase in incorporation is seen. 
This suggests that in the isolation of rat glomeruli free radical
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proline. This is not surprising when one considers that the 
sieving procedure damages many cells releasing their cellular 
contents into the medium, the generation of reactive oxygen 
species some of these constituents is well established (Eling et 
al., 1983).
The idea that ADR toxicity may be free radical mediated has 
recently been supported by (Geetha et al., 1990), who also have 
reported that ADR toxicity can be reduced by the oral 
administration of alpha-tocopherol in rats. Alpha-tocopherol has 
been used to inhibit microsomal and mitochondrial lipid 
peroxidation in-vitro (Mimnaugh et al, 1986). The effect of 
alpha-tocopherol on adriamycin induced toxicity in isolated 
glomeruli requires further investigation.
4.4 Radiolabelled precursors studies with isolated pig glomeruli. 
Although adriamycin induced nephrosis is well established in the 
rat, there is a paucity of evidence to show that adriamycin is 
nephrotoxic in man. The marked effect of adriamycin in the rat 
glomeruli prompted the investigation of other species, and 
isolated pig glomeruli were studied. Isolated pig glomeruli, like 
rat, incorporate proline and thymidine, but to a much lesser 
extent. This may be a species difference or in the quality of the 
glomeruli isolated. The later may be due to the fact that the 
kidneys are obtained from the abattoir which means that no 
information on the age, sex or health of the animal is available. 
Furthermore, during transport the kidneys are kept on ice for at 
least one hour before they are used for the isolation of
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become less metabolically active. Further more the fiberous 
nature of the pig kidney means that harsher isolation procedures 
have to be used (see methods).
The potency of inhibitory action of streptomycin and HCBD- 
cysteine on proline incorporation is greater than in the rat. 
This is probably due to the fact that initial incorporation is 
low, therefore even the slightest effect may appear greater as a 
percentage of control. BEA, FEA and BPA are less potent 
inhibitors of proline than the other compounds studied suggesting 
that some selectivity of inhibition exists. Polybrene is less 
potent in inhibiting proline incorporation in the pig than in the 
rat. This may have some relation to the greater mass of fibrous 
tissues in pig glomeruli compared to the rat. So if polybrene has 
a detergent like action, as its prime means of toxicity, the 
fibrous tissue may act as a "buffer11 restricting the access to 
cellular sites which are likely to be damaged. Delacruz, (1988) 
has recently shown that adriamycin does inhibit proline 
incorporation into isolated pig glomeruli to a greater extent 
than lysine. Thus suggesting that glomerular cells in-vitro are 
highly sensitive to adriamycin toxicity. Recent data has shown 
that a nephrotic syndrome occurs in pigs dosed with > 1.5 mg/kg 
adriamycin by 12 weeks (Robbins et al., 1991, unpublished). 
Previously the effect of ADR on glomeruli was regarded as species 
specific to rodents. This is obviously not the case and the 
relevance to man requires further investigation.
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Glomeruli from rat and pig can be isolated and kept viable for at 
least 4 hours as shown by enzyme leakage, amino acid 
incorporation, thymidine incorporation and ATP content.
Although LDH was found to give an indi c a t i o n  of ADR 
cytotoxicity, enzyme leakage was not a sensitive indicator of 
glomerular toxicity. This may be due to the generally low levels 
of any particular enzyme and the presence of proteolytic enzymes 
in the glomerulus.
Protein synthesis especially the incorporation of proline is a 
sensitive and selective indicator of glomerular toxicity. ADR = 
pharmarubicin = polybrene > STREPT = paraguat > Pu.A > BEA > BPA. 
For pig glomeruli this was Polybrene > HCBD > BEA > FEA = BPA.
The synthesis of GBM is active in isolated rat glomeruli. This 
is suggested by 55 % of the proline and 70 % of lysine being 
associted with the GBM.
Although lysine was incorporated into the GBM to a greater extent 
than proline, proline was a more sensitive indicator of 
cytotoxicity. This suggests that the component of the GBM that 
requires proline for its synthesis is of primery importance to 
the integrity of the glomerulus.
Glucose oxidatin and the PPP are active in the isolated rat 
glomeruli. This can be stimulated by redox cycling toxins such as 
ADR and paraquat. The radical scavenger desferroxime is able to
115
The addition of radical scavengers to isolated rat glomeruli 
increased proline, reduced thymidine incorporation, and decreased 
PPP activity. This suggests that free radical mediated damage 
occurs to glomeruli during isolation. The addition of exogenous 
free radical scavengers to the medium during isolation may 
prevent such damage.
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The studies reported in this thesis suggests that adriamycin 
produces a selective inhibition of proline incorporation in rat 
glomeruli. A considerable p r o p ortion of this p r oline 
incorporated, was associated with the GBM. It is interesting that 
although lysine is incorporated into the GBM to a greater extent 
than proline, proline incoporation was affected by toxins to a 
greater extent. These studies need to be extended to define:
Why is this proline incorporation so susceptible.
What is the nature of the de-novo proteins synthesised by 
isolated glomeruli.
What is the role of these proteins within the glomerulus.
Delacruz, 1988 has shown that the aromatic amino acids tryptophan 
and tyrosine are incorporated into isolated rat glomeruli to a 
greater extent than proline. The role of these amino acids in 
adriamycin induced glomerular toxicity and the extent of 
involvment in GBM/extracellular matrix synthesis requires 
investigation.
Adriamycin has been shown to be taken up by glomerular epitheial 
cells, are these the site of proline incorporation.
There is a need to establish why glomerular epitheial cells are 
the target for many glomerular toxins. Studies (Marsh and Centre, 
1985) on cell lines have shown differences in the membrane 
proteins, receptors, transport systems etc. a comparison of 
sensitive and resistant cells could help define the processes
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adriamycin have the ability to actively exclude adriamycin. 
(Vrignaud et al., 1986) have shown that rat glomerular cells in 
culture that are resistant to adriamycin have a 5 fold reduced 
incorporation of adriamycin due to an increased efflux. One of 
the important question is do mesangial and endothelial cells 
possess this increased efflux?
Both epithelial and mesangial cells can be cultured separately, 
although it is difficult to culture endothelial cells, (see 
introduction). This would allow the molecular basis of selective 
toxicity to be further investigated.
Earlier in this thesis (section 1.0) the differences in metabolic 
profile of the various cells was documented. These differences 
(e.g. prostaglandin synthesis) could be used to further 
investigate target cell toxicity of adriamycin.
The current studies have demonstrated a stimulation of PPP in 
isolated glomeruli, exposed to adriamycin. Cultured mesangial or 
epithelial cells could similarly be used to link the role of 
redox cycling with nephro-protectants (i.e. free radicals 
scavengers). That may be useful in-vivo.
The effects of adriamycin on GSH content and subsequent 
consequences could be investigated using GSH depleters such as 
diethyl maleate and inhibitors of GSH synthesis such as 
butathionine sulfoximine.
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Solutions
The Tyrode solution is made daily from two "stock11 solutions A 
and B. The composition of these solutions is as follows:
STOCK A
CONSTITUENT 5
VOLUME (L). 
4 3 2 1
NaCl lOOOg 800g 600g 400g 200g
KCl 25g 20g 15g lOg 5g
MgCl2 .6H20 26.5g 21.5g 15.7g 10.6g 5. 3g
CaCl2 .2H20 12.5ml 90ml 60.75ml 45ml 22.5ml
STOCK B
CONSTITUENT 5 4
(L)
3 2 1
NaHC03 250g 200g 150g lOOg 50g
NaH2P04 .2H20 16. 3g 13g 9. 8g 6. 5g 3.26g
The Tyrode solution was prepared by mixing the required quantity 
of stock solution A with glass-distilled water (about half the 
total volume of Tyrode's required). The quantity of stock B was 
then added with glucose and the solution made up to the 
appropriate volume using distilled water. The quantities of 
stock A, B and glucose used for each volume of Tyrode's solution 
were as shown.
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CONSTITUENT 101 51 41 31 21 11
STOCK A 4 00ml 2 00ml 160ml 12 0ml 80ml 40ml
STOCK B 2 00ml 100ml 80ml 60ml 4 0ml 2 0ml
d i s t .h 2o 9400ml 4700ml 3760ml 2820ml 1880ml 940ml
GLUCOSE lOg 5g 4g 3g 2g ig
The final composition of this Tyrode's solution was as follows
CONSTITUENT CONCENTRATION MOLARITY
NaCl 8.0g/l 137mM
KC1 0.1g/l 2. 7mM
CaCl2 0.4g/l 0. 8mM
MgCl2 0.1g/l 1.04mM
NaH2P04 .2H20 0.05g/l 0.42mM
NaHC03 1.0g/l 12.OmM
Glucose 1.0g/l 5. 5mM
149
APPENDIX II.
Stainless steel sieve 
Aluminium funnel
sealing "o" ring
Aluminium sieve holder
Sartorius filter tower
Apparatus used for the isolation of glomeruli from 
minced corticies (see sections 2.1 and 2.2).
A PP ENDIX III
ALKALINE PHOSPHATASE RELEASE FRO M  ISOLATED RAT GLOMERULI
COMPOUND CONCENTRATION(mM) MEAN STD ERROR T VALUE P N
STREPTOMYCIN 3.4 1.82 X 10~4 4.55 X 10“5 0.781 NS 4
SULPHATE 6.9 1.30 X 10“4 2.5 X 10“5 1.040 NS 4
13.7 1.87 X IO"4 3.5 X 10"5 0.765 NS 4
27.4 1.90 X 10-4 3.8 X IO"5 0.749 NS 4
POLYBRENE 0.7 1.5 X io-4 3.3 X 10“5 0.940 NS 4
1.3 2.0 X 10~4 4.0 X 10“5 0.701 NS 4
2.7 2.6 X IO"4 3.0 X IO"5 0.424 NS 4
5.3 3.5 X io-4 9.3 X io-6 0 NS 4
PUROMYCIN 5.3 2.4 X 10"4 2.2 X 10“5 0.520 NS 4
AMINO- 10.6 2.9 X 10"4 4.5 X IO"5 0.279 NS 4
NUCLEOSIDE 21.2 1.21 X io-4 3.3 X io-5 1.077 NS 4
42.4 1.00 X IO"4 2.8 X 10“5 1.180 NS 4
BR0M0- 24.4 8.2 X IO’5 1.3 X IO"5 1.273 NS /4
ETHANAMINE 48.8 1.0 X 10~4 2.2 X IO"5 1.183 NS 4
97.6 6.9 X IO"5 1.1 X IO"5 1.336 NS 4
195.1 1.25 X IO’4 2.8 X 10“6 1.071 NS 4
FLU0R0- 35.3 3.0 X IO"5 1.1 X 10“5 1.521 NS 4
ETHANAMINE 70.7' 6.7 X IO"5 1.1 X IO"5 1.345 NS 4
141.3 1.6 X IO"5 2.2 X IO"5 1.581 NS 4
282.7 8.15 X IO"5 2.3 X IO"5 1.270 NS 4
BR0M0- 28.7 1.1 X IO"4 3.5 X IO"5 1.127 NS 4
PROPANAMINE 57.3 5.6 X IO"5 2.4 X io-5 1.390 NS 4
114.6 9.2 X IO"5 2.8 X 10“5 1.217 NS 4
229.2 1.6 X IO”4 4.3 X IO"5 0.886 NS 4
CONTROL NA 3.5 X IO"4 2.1 X IO"4 14
SONICATED NA 2.8 X 10“3 0.9 X IO"3 14
NA = Not applicable.
NS = Not significant
Figures represent enzyme units/mg glomerular protein.
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APPENDIX IV
LDH RELEASE FROM ISOLATED RAT GLOMERULI
COMPOUND CONCENTRATION(mM) MEAN STD ERROR T VALUE P N
STREPTOMYCIN 3.4 538.14 90.2 0.026 NS 4
SULPHATE 6.9 551.3 74.6 0.191 NS 4
13.7 549.7 79.8 0.162 NS 4
27.4 496.8 66.8 0.516 NS 4
POLYBRENE 0.7 1160.1 189.9 3.235 <0.005 4
1.3 1360.1 229.9 3.546 <0.005 4
2.7 1355.2 251.0 3.235 <0.005 4
5.3 1184.6 226.6 2.831 <0.0 1 4
PUROMYCIN 5.3 418.4 545.0 0.2146 NS 4
AMINO- 10.6 444.6 54.7 1.408 NS 4
NUCLEOSIDE 21.2 360.8 47.1 2.997 <0.005 4
42.4 302.0 30.4 5.088 <0.0005 4
BR0M0- 24.4 303.6 58.4 3.422 <0.00' 5 4
ETHANAMINE 48.8 178.6 41.3 6.641 <0.0005 4
97.6 163.0 38.4 7.227 <0.0005 4
195.1 147.0 34.3 7.999 <0.0005 4
FLU0R0- 35.3 468.8 65.1 0.907 NS 4
ETHANAMINE 70.7' 516.3 97.9 0.185 NS 4
141.3 900.6 174.3 2.054 NS 4
282.7 1596.4 148.9 6.941 <0.0005 4
BROMO- 28.7 630.6 156.8 0.591 NS 4
PROPANAMINE 57.3 1343.7 368.6 2.182 NS 4
114.6 1417.9 373.7 2.351 NS 4
229.2 1375.3 349.6 2.390 NS 4
CONTROL NA 535.6 34.4 14
SONICATED NA 1658.9 68.5 14
NA = Not applicable.
NS = Not significant
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APPENDIX V
a  GT RELEASE FROM ISOLATED RAT GLOMERULI
COMPOUND CONCENTRATION(mM) MEAN STD ERROR T VALUE P N
STREPTOMYCIN 3.4 23.14 5.0 0.792 NS 4
SULPHATE 6.9 12.91 2.0 5.618 <0.0005 4
13.7 11.51 2.5 5.319 <0.0005 4
27.4 15.5 3.9 2.799 <0.01 4
POLYBRENE 0.7 36.4 8.2 1.089 NS 4
1.3 31.0 2.9 1.117 NS 4
2.7 41.0 9.7 1.393 NS 4
5.3 27.0 4.3 0.065 NS 4
PUROMYCIN 5.3 43.6 9.0 1.783 NS 4
AMINO- 10.6 31.6 5.6 0.738 NS 4
NUCLEOSIDE 21.2 21.4 5.5 1.030 NS 4
42.4 12.1 1.3 7.373 <0.0005 4
BR0M0- 24.4 10.4 1.0 8.956 <0.0005 4
ETHANAMINE 48.8 11.25 1.7 6.875 <0.0005 4
97.6 8.75 0.8 1.036 NS 4
195.1 16.2 3.2 3.102 <0.005 4
FLU0R0- 35.3 28.2 4.2 0.200 NS 4
ETHANAMINE 70.7' 37.8 11.5 0.904 NS 4
141.3 21.4 3.1 1.691 NS 4
282.7 59.1 13.7 2.305 NS 4
BR0M0- 28.7 41.64 10.2 1.388 NS 4
PROPANAMINE 57.3 58.9 15.7 2.002 NS 4
114.6 37.7 5.7 1.756 NS 4
229.2 55.8 6.1 4.519 <0.0005 4
CONTROL NA 27.3 1.6 14
SONICATED NA 142.6 6.7 14
NA = Not applicable.
NS = Not significant
Figures are units/mg glomerular protein.
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APP EN D IX  VI
NAG RELEASE FROM ISOLATED RAT GLOMERULI
COMPOUND CONCENTRATION(mM) MEAN STD ERROR T YALUE P N
STREPTOMYCIN 3.4 14.0 4.3 0.288 NS 4
SULPHATE 6.9 7.4 2.4 2.05 NS 4
13.7 5.3 2.2 3.074 <0.005 4
27.4 1.3 2.6 4.103 <0.0005 4
POLYBRENE 0.7 15.72 1.2 1.914 NS 4
1.3 32.76 8.3 2.395 NS 4
2.7 26.7 6.5 2.124 NS 4
5.3 10.9 2.3 0.7296 NS 4
PUROMYCIN 5.3 7.3 1.6 2.877 <0.01 4
AMINO- 10.6 10.3 2.3 0.968 NS 4
NUCLEOSIDE 21.2 23.8 6.5 1.683 NS 4
42.4 40.6 10.5 2.642 <0.01 4
BR0M0- 24.4 4.8 0.8 6.192 <0.0005 4
ETHANAMINE 48.8 9.5 0.7 2.646 <0.01 4
97.6 8.8 2.1 1.689 NS 4
195.1 9.9 1.9 1.318 NS 4
FLU0R0- 35.3 100.2 32.8 2.665 <0.01 4
ETHANAMINE 70.7' 124.9 35.6 3.149 <0.005 4
141.3 160.5 50.1 2.948 <0.005 4
282.7 151.6 47.5 2.922 <0.005 4
BR0M0- 28.7 14.5 2.1 0.760 NS 4
PROPANAMINE 57.3 15.4 2.3 1.064 NS 4
114.6 21.4 1.5 4.809 <0.0005 4
229.2 72.3 13.5 4.400 <0.0005 4
CONTROL NA 12.73 1.0 14
SONICATED NA 63.0 3.0 14
NA = Not applicable.
NS = Not significant
Figures represent units/mg glomerular protein.
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APP EN D IX  VII
GALACTOSIDASE RELEASE FROM ISOLATED RAT GLOMERULI
COMPOUND CONCENTRATION(mM) MEAN STD ERROR T VALUE P N
STREPTOMYCIN 3.4 16.3 3.2 0 NS 4
SULPHATE 6.9 17.0 2.1 0.295 NS 4
13.7 11.6 3.2 1.3889 NS 4
27.4 10.7 3.0 1.752 NS 4
POLYBRENE 0.7 10.5 1.4 3.257 <0.005 4
1.3 8.6 1.4 4.324 <0.0005 4
2.7 9.5 0.8 4.999 <0.0005 4
5.3 8.1 2.9 2.643 <0.01 4
PUROMYCIN 5.3 12.7 3.0 1.126 NS 4
AMINO- 10.6 3.9 1.5 6.666 <0.0005 4
NUCLEOSIDE 21.2 2.8 1.8 6.399 <0.0005 4
42.4 5.7 2.2 4.309 <0.0005 4
BR0M0- 24.4 5.7 1.2 6.511 <0.0005 4
ETHANAMINE 48.8 11.7 3.1 1.398 NS 4
97.6 16.5 1.9 0.091 NS 4
. 195.1 9.5 1.8 3.223 <0.005 4
FLU0R0- 35.3 15.68 3.6 0.164 NS 4
ETHANAMINE 70.7' 31.21 5.1 2.857 <0.01 4
141.3 27.7 4.6 2.410 NS 4
282.7 34.4 4.0 4.363 <0.0005 4
BR0M0- 28.7 90.9 26.4 2.823 <0.01 4
PROPANAMINE 57.3 75.7 14.5 4.084 <0.0005 4
114.6 90.0 18.0 4.086 <0.0005 4
229.2 117.5 26.5 3.815 <0.005 4
CONTROL NA 16.3 1.1 14
SONICATED NA 55.3 2.4 14
NA = Not applicable.
NS = Not significant
Figures represent enzyme units/mg glomerular protein
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APPENDIX VIII
EFFECT OF C OMPOUNDS ON ALKALINE PHOSPHATASE ACTIVITY
IN WHOLE RAT KIDNEY HOMOGENATE
COMPOUND CONCENTRATION(mM) MEAN STD ERROR T VALUE P N
STREPTOMYCIN 6.9 939 76.8 0.919 NS 3
SULPHATE 13.7 1010 73.9 0.163 NS 3
27.4 835 12.1 2.483 NS 3
POLYBRENE 1.3 1635 109.6 8.339 <0.005 3
2.7 1388 43.3 7.796 <0.005 3
5.3 1496 80.8 7.85 <0.005 3
PUROMYCIN 10.6 658 23.7 7.483 <0.005 3
AMINO­ 21.2 744 82.6 3.973 <0.01 3
NUCLEOSIDE 42.4 886 18.8 2.483 NS 3
BR0M0- 48.8 932.7 42.0 1.296 < NS 3
ETHANAMINE 97.6' 840 45.7 3.145 <0.01 3
195.1 646.5 10.5 8.000 <0.005 3
CONTROL NA 996.1 75 i - 3
NA = Not applicable.
NS = Not significant 
Figures a r e  u n i t S / f n g p r o t e i n .
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APPENDIX IX
EFF EC T  OF COMPOUNDS ON LDH ACTIVITY IN RAT
W HOLE RAT KIDNEY HOMOGENATE
COMPOUND CONCENTRATION(mM) MEAN STD ERROR T VALUE P N
STREPTOMYCIN 6.9 720 11.3 16.42 <0.0005 3
SULPHATE 13.7 680 4.6 21.24 <0.0005 3
27.4 595 6.8 27.35 <0.0005 3
POLYBRENE 1.3 887 12.1 4.22 <0.005 3
2.7 872 19.9 4.465 <0.01 3
5.3 931 21.9 0.913 NS 3
PUROMYCIN 10.6 826 5.7 9.538 <0.0005 3
AMINO- 21.2 750 34.9 8.422 <0.005 3
NUCLEOSIDE 42.4 803.4 6.7 11.175 <0.0005 3
BR0M0- 48.8 860.0 19.1 5.267 <0.005 3
ETHANAMINE 97.6' 868.6 43.3 2.724 NS 3
195.1 863.3 17.9 5.168 <0.005 3
CONTROL NA 947 21.6 - - 3
NA = Not a D D l i c a b l e .
NS = Not significant
Figures are units/g protein.
APP EN D IX  X
EFFECT OF COMPOUNDS ON tf-GLUTAMYL TRANSPEPTIDASE ACTIVITY
IN WHOLE RAT KIDNEY HOMOGENATE
COMPOUND CONCENTRATION(mM) MEAN STD ERROR T VALUE P N
STREPTOMYCIN 6.9 795.7 3.9 8.529 <0.005 3
SULPHATE 13.7 742.3 10.5 5.055 <0.005 3
27.4 703.8 32.2 3.495 NS 3
POLYBRENE 1.3 772.5 81 0.325 NS 3
2.7 757.4 24.2 1.186 NS 3
5.3 750.9 41.0 0.977 NS 3
PUROMYCIN 10.6 788.9 61 3.915 <0.01 3
AMINO- 21.2 811.1 87 7.060 <0.005 3
NUCLEOSIDE 42.4 777.3 53 0.949 NS 3
BR0M0- 48.8 712.9 52 2.042 NS 3
ETHANAMINE 97.6 780.9 11.5 1.026 NS 3
195.1' 791.4 21.7 1.370 NS 3
CONTROL NA 774 18 3
NA = Not applicable.
NS = Not significant
Figures represent units/mg glomerular protein
APPENDIX XI
EFFECT OF COMPOUNDS ON GALACTOSIDASE ACTIVITY
IN WHOLE RAT KIDNEY HOMOGENATE
COMPOUND CONCENTRATION(mM) MEAN STD ERROR T VALUE P N
STREPTOMYCIN 6.9 9.57 0.5 15.37 <0.0005 3
SULPHATE 13.7 15.24 0.46 9.140 <0.0005 3
27.4 14.96 0.46 9.407 <0.0005 3
POLYBRENE 1.3 20.0 3.64 1.411 NS 3
2.7 23.16 2.25 0.015 NS 3
5.3 26.7 0.92 3.566 NS 3
PUROMYCIN 10.6 13.68 0.67 10.414 <0.0005 3
AMINO- 21.2 12.10 0.13 13.34 <0.0005 3
NUCLEOSIDE 42.4 15.6 0.21 9.067 <0.0005 3
BR0M0- 48.8 10.90 0.50 14.04 <0.0005 3
ETHANAMINE 97.6' 14.60 0.70 9.33 <0.0005 3
195.1 26.7 0.92 6.311 <0.005 3
CONTROL NA 23.19 2.5 3
NA = Not applicable.
NS = Not significant
Figures represent enzyme units/mg glomerular protein
APPENDIX XII
EFFECT OF COMPOUNDS ON NAG ACTIVITY
IN RAT WHOLE KIDNEY HOMOGENATE
COMPOUND CONCENTRATION(mM) MEAN STD ERROR T VALUE P N
STREPTOMYCIN 6.9 43.07 3.18 12.89 <0.0005 3
SULPHATE 13.7 45.19 3.18 11.9 <0.0005 3
27.4 32.34 2.66 20.90 <0.0005 3
POLYBRENE 1.3 81.1 1.25 11.21 <0.0005 3
2.7 102.2 0.55 37.90 <0.0005 3
5.3 104.6 0.78 37.95 <0.0005 3
PUROMYCIN 10.6 61.67 1.36 6.24 <0.005 3
AMINO- 21.2 60.94 1.5 6.48 <0.005 3
NUCLEOSIDE 42.4 72.1 0.7 3.65 NS 3
BR0M0- 48.8 42.38 0.04 30.28 <0.0005 3
ETHANAMINE 97.6' 38.83 1.8 22.34 <0.0005 3
195.1 43.32 1.44 21.80 <0.0005 3
CONTROL NA 68.73 1.44
NA = Not applicable.
NS = Not significant
Figures represent enzyme units/mg glomerular protein
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APPENDIX XIII
INCORPORATION OF 3h-PR0LINE INTO ISOLATED PIG GLOMERULI
COMPOUND CONCENTRATION(mM) MEAN S.E.M T YALUE P N
Time 2 hr 0.0218 1.4 X 10-3 3
4 - 0.0534 2.6 X 10-3 3
8 - 0.0775 2.0 X 10-3 3
POLYBRENE 0.35 0.037 2.8 X IO-3 4.292 <0.01 3
0.70 0.036 4.8 X 10-3 3.1874 NS 3
1.35 0.034 1.2 X 10-3 6.774 <0.005 3
STREPTOMYCIN 3.4 0.0229 3.3 X IO"3 7.259 <0.005 3
7 0.0198 2.1 X 10-3 10.05 <0.0005 3
14 0.0130 1.8 X 10-3 12.77 <0.0005 3
BR0M0- 12 0.019 1.7 X IO"3 11.073 <0.0005 3
ETHANAMINE 24 0.015 8.6 X IO"4 14.022 <0.0005 3
48 0.010 5.1 X IO"4 16.380 <0.0005 3
BR0M0- 28.7 0.0561 2.1 X IO-3 0.807 NS 3
PROPANAMINE 57.3 0.0282 3.2 X 10-3 6.1118 <0.0005 3
114.3 0.0274 1.8 X 10-3 14.390 <0.0005 3
FLU0R0- 35.3' 0.0545 1.9 X IO"3 0.3415 NS 3
ETHANAMINE 70.7 0.0211 5.1 X 10-3 5.642 <0.005 3
141.3 0.0187 8.1 X 10-4 12.742 <0.0005 3
HCBD- 1 0.0378 2.0 X IO"3 4.7557 <0.005 3
CYSTEINE 2 0.0206 2.5 X 10-3 9.093 <0.0005 3
4 0.0026 1.4 X 10-3 17.203 <0.0005 3
NS = Not significant
Figures represent Picomol / mg glomerular protein
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APPENDIX XIV
INCORPORATION OF 3 H-THYMIDINE INTO ISOLATED PIG GLOMERULI
COMPOUND CONCENTRATION(mM) MEAN S.E.M T YALUE P N
Time 2 hr 0.00105 4.6 x io-5 3
4 - 0.00112 3.8 x 10"5 3
8 0.00306 5.1 x 10“b 3
POLYBRENE 0.7 0.00051 7.1 x 10-5 7.5749 <0.005 3
1.3 0.00049 8.3 x 10-5 6.9014 <0.005 3
2.7 0.00059 1.0 x IO"4 4.9544 <0.005 3
STREPTOMYCIN 3.4 0.00147 5.2 x IO"5 5.434 <0.005 3
SULPHATE 7 0.00121 5.6 x 10-5 1.3299 NS 3
14 0.00145 6.1 x 10-5 4.5918 <0.01 3
BR0M0- 24 0.00064 4.1 x 10-5 8.5865 <0.005 3
ETHANAMINE 48 0.00133 3.2 x IO"4 0.6517 NS 3
98 0.00052 8.1 x 10-5 6.7061 <0.005 3
BR0M0- 28.7 0.00268 5.1 x IO"5 24.528 <0.0005 3
PROPANAMINE 57.3 0.00101 6.3 x 10-5 1.4951 NS 3
114.6 0.00109 5.6 x 10-5 0.4433 NS 3
FLU0R0- 35.3' 0.00145 5.2 x IO"5 5.1238 <0.005 3
ETHANAMINE 70.7 0.00035 4.1 x 10-5 13.7741 <0.0005 3
141.3 0.00096 8.0 x 10-5 1.8066 NS 3
HCBD- 1 0.0009 4.4 x IO"5 3.7841 <0.01 3
CYSTEINE 2 0.0013 3.9 x 10-5 3.3057 NS 3
4 0.0019 6.4 x 10-5 10.4795 <0.0005 3
NS = Not significant
Figures represent picomol / mg glomerular protein
A PP ENDIX XV
EFFECT OF RADICAL SCAVENGERS ON THE ADRIAMYCIN INDUCED INHBITION
OF 3H-PR0LINE INCORPORATION INTO ISOLATED RAT GLOMERULI
COMPOUND CONCENTRATION MEAN S.E.M T VALUE P N
ADRIAMYCIN 0.16mM 0.0740 0.0132 - 6
ADr + 
HISTIDINE 1 OOpM 0.0768 0.0092 0.1740 NS 3
HISTIDINE 1 OOpiM 0.7801 0.0560 12.2725 <0.0005 3
ADr + SOD lOOpg/ml 0.1002 0.0476 0.530 NS 3
SOD lOOpg/ml 0.8504 0.0623 12.1916 <0.0005 3
ADr +
MANNITOL • lOOpM 0.2174 0.0625 2.2448 NS 3
MANNITOL lOOpM 0.3396 0.0750 3.4877 <0.01 3
ADr +
GLUTATHIONE IOOmM 0.0784 0.0114 0.2522 NS 3
GLUTATHIONE lOOpM 0.4967 0.0442 9.1634 <0.0005 3
NS = Not significant 
ADr = adriamycin
/ me glomerular protein 
Figures represent picomol / & &
U 3
APPENDIX XVI
EFF EC T  OF FREE RADICAL S CAVENGERS ON THE ADRIAMYCIN INDUCED INHBITION
OF 3h-THYMIDINE INCORPORATION INTO ISOLATED RAT GLOMERULI
COMPOUND CONCENTRATION MEAN S.E.M T VALUE P N
ADRIAMYCIN 0.16mM 0.0605 3.46 x IO'3 - 6
ADr + 
HISTIDINE lOO^ M 0.0546 6.8 x IO"3 0.7667 NS 3
HISTIDINE IOOjjM 0.1200 00455 1.3039 NS 3
ADr + SOD loong/mi 0.0488 3.38 x IO'3 2.4189 NS 3
SOD lOO^ g/ml 0.1520 0.0389 2.3429 NS 3
ADr + 
MANNITOL TOOpM 0.0844' 6.74 x IO*3 3.2217 <0.01 3
MANNITOL lOOpM 0.0937 0.0240 1.3692 NS 3
ADr +
GLUTATHIONE lOO^ M 0.0411 2.37 x IO*3 4.6258 <0.005 3
GLUTATHIONE lOOpM 0.0424 1.5 x IO"3 4.7757 <0.005 3
ADr = adriamycin
NS = Not signif icant F:j . . .  ^ .
igures represent picomol / mg glomerular Protein
UH
APPENDIX XVII
THE EFFECT OF 3H-PRQLINE INCORPORATION INTO ISOLATED 
RAT GLOMERULI OVER 4 HOURS p mol ,/mg GLOMERULAR PROTEIN
COMPOUND CONCENTRATION(mM) MEAN S.E.M T VALUE P N
Time 1 hour 0.0570 2 x 10“3 4
2 - 0.161 0.025 4
4 - 0.362 0.0023 4
ADRIAMYCIN 0.0312 0.301 0.03 2.0274 NS 3
0.0625 0.194 0.017 9.793 <0.0005 3
0.125 0.1245 4 x IO"3 51.472 <0.0005 3
0.25 0.1245 0.010 23.146 <0.0005 3
PHARMA- 0.0312 0.248 0.033 3.4462 <0.005 3
RUBICIN 0.0625 0.166 7.9 x IO"3 23.821 <0.0005 3
0.125 0.120 6.1 x IO”3 37.121 <0.0005 3
0.25 0.107 0.0115 21.743 <0.0005 3
PUROMYCIN 1.25 0.269 0.052 1.7867 NS 3
AMINO- 2.5 0.298 0.050 1.2786 NS 3
NUCLEOSIDE 5.0 0.199 0.010 15.885 <0.0005 3
10.0 0.169 0.030 6.414 <0.005 3
POLYBRENE 0.0125 0.121 1.1 x IO"3 94.527 <0.0005 3
0.025 0.107 1.2 x IO”3 98.295 <0.0005 3
0.05 0.108 2.9 x IO"3 68.623 <0.0005 3
0.0625 0.038 4.0 x IO"3 70.219 <0.0005 3
0.125 0.037 0.0133 24.079 <0.0005 3
0.25 0.042 4.0 x IO”3 69.353 <0.0005 3
0.35 0.037 8.0 x IO’3 39.043 <0.0005 3
0.50 0.041 6.9 x IO-3 44.134 <0.0005 3
0.7 0.0451 0.0110 28.199 <0.0005 3
1.3 0.0275 5.2 x IO-3 58.829 <0.0005 3
2.7 0.0270 5.2 x 10-3 58.917 <0.0005 3
STREPTOMYCIN 3.4 0.0820 0.0127 21.694 <0.0005 3
6.9 0.0435 4.5 x IO”3 63.023 <0.0005 3
13.7 0.0268 9.8 x IO’3 33.299 <0.0005 3
NS = Not significant
APPENDIX XVII - continued 
THE EFFECT OF 3H-PRQLINE INCORPORATION INTO ISOLATED 
RAT GLOMERULI OVER 4 HOURS p mol /mg GLOMERULAR PROTEIN
COMPOUND CONCENTRATION(mM) MEAN S.E.M T VALUE P N
BPA 14.35 0.3725 0.080 0.131 NS 4
28.7 0.1175 0.009 25.783 <0.0005 4
57.3 0.062 0.038 7.8803 <0.0005 4
BEA 12.2 0.041 0.031 10.326 <0.0005 4
24.2 0.024 0.095 3.5526 <0.005 4
48.8 0.035 0.04 8.1615 <0.0005 4
97.6 0.0049 0.03 11.868 <0.0005 4
HCBD- 0.25 0.4236 2
CYSTEINE 0.5 0.3834 2
1.0 0.4185 2
2.0 0.3657 2
10.0 0.0532 2
NS = Not significant
APPENDIX XVIII
THE EFFECT OF VARIOUS COMPOUNDS ON 3H-HISTIDINE 
INCORPORATION INTO ISOLATED RAT GLOMERULI
COMPOUND
CONCENTRATION
(mM) MEAN S.E.M T VALUE P N
Time 1 hour 0.033 0.015 3
2 - 0.093 0.017 3
4 - 0.1938 0.0075 3
ADRIAMYCIN 0.25 0.1658 0.0147 1.6966 NS 3
0.5 0.0856 0.0232 0.4661 NS 3
1.0 0.1181 0.0042 8.806 <0.0005 3
POLYBRENE 0.25 0.0597 0.017 7.217 <0.0005 3
0.5 0.0733 0.026 4.453 <0.01 3
1.0 0.0910 0.024 4.088 <0.01 3
NS = Not significant
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A PP ENDIX XIX
THE EFFECT OF VARIOUS COMPOUNDS ON 3h~LYSINE 
INCORPORATION INTO ISOLATED RAT GLOMERULI 
(p mol /mg glomerular protein)
COMPOUND
CONCENTRATION
(mM) MEAN S.E.M T YALUE P N
Time 1 hour 0.1355 0.038 3
2 - 0.261 0.038 3
4 - 0.558 0.092 3
ADRIAMYCIN 0.25 0.585 0.138 0.1627 NS 3
0.5 0.445 0.132 0.7023 NS 3
1.0 0.522 0.159 0.1960 NS 3
POLYBRENE 0.25 0.5375 0.098 0.1525 NS 3
0.5 0.493 0.152 0.3658 NS 3
1.0 0.462 0.142 0.5674 NS 3
NS = Not significant
it?
APPENDIX XX
THE EFFECT OF VARIOUS COMPOUNDS ON 3H-THYMIDINE
INCORPORATION INTO ISOLATED RAT GLOMERULI 
(p mol /mg glomerular protein)
COMPOUND CONCENTRATION(mM) MEAN S.E.M T VALUE P N
Time 1 hour 0.0131 0.0072 4
2 - 0.0525 0.0144 4
4 - 0.1815 0.029 4
STREPTOMYCIN 3.4 0.2473 0.0170 1.957 NS 3
6.9 0.2901 0.0381 0.0479 NS 3
13.7 0.2688 0.0577 1.3518 NS 3
POLYBRENE 0.35 0.0886 0.0326 2.1292 NS 3
0.7 0.0938 0.0040 2.9957 NS 3
1.3 0.0828 0.0138 3.0732 NS 3
2.7 0.0251 0.0431 3.0106 NS 3
ADRIAMYCIN 0.625 0.1883 0.023 0.1837 NS 3
1.25 0.0483 0.046 0.0553 NS 3
2.5 0.0629 0.032 2.7463 NS 3
BPA 14.35 0.3372 0.079 1.850 NS 3
28.7 ' 0.2492 0.121 0.5441 NS 3
57.3 0.0677 0.024 3.0231 NS 3
114.6 0.0507 0.021 3.6531 NS 3
BEA 12.2 0.1241 0.063 0.8276 NS 3
24.4 0.1055 0.049 1.3348 NS 3
48.8 0.0613 0.020 3.412 NS 3
97.6 0.0521 0.019 3.732 NS 3
Pu.A 0.05 0.1447 2
0.5 0.0915 2
5.0 0.0929 2
NS = Not significant
A mmo acid mcoirpuxai-xuji xiiuu UrX5ivi .  a s  a iunctj-un ux uuuax cu u x jiu  auiu 
incorporation into isolated rat glomeruli.
Proline
Lysine
Histidine
% Total
55.5 +/“ 4 
69.1 +/“ 7
14.5 +/" 1
n = 3 figures mean +/- SEM
pmol/mq protein 
0.201 + / “ 
0.386 +/" 
0.028 +/“
.046
.112
.002
\70
Perturbation by aesrernoxime (ues; or pentose snunc srimuiarion maucea d
Adriamycin on paraquat(pq)
Cl-GLUC C6-GLUC RATIO
Control 1 1707 1064 1.6
Control 2 1655 1318 1.26
0.25mM pq 4010 995 4.03
0.25mM pq + Des 3643 1560 2.33
0.25mM ADr 3688 845 4.36
0.25mM ADr + Des 3993 1272 3.14
1 Des 2663 1295 2.0
2 Des 2300 1032 2.2
Figures represent DPM/mg glomeruli protein. 
GLUC = glucose
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Pentose shunt stimulation by Adriamycin.
Cone.
mM n
Cl--GLUC Cl-GLUC C1/C6
0 8 1885 +/“ 598 1204 +/“ 558 1.56
0.125 4 2875 +/“ 328 1315 +/“ 132 2.18
0.25 4 3658 +/“ 243 1295 +/- 131 2.82
0.5
GLUC =
4
Glucose
3890 +/" 163 911 +/“ 293 4.27
Cone = concentration
Mean DPM/mg glomeruli protein +/- standard deviation.
172.
Time dependent stimulation of pentose shunt by parag
TIME (hours)
1 2 4
Paracruat (0. 5mM}
Cl-GLUC 1642 4016 7710
C6-GLUC 759 1449 3922
C1/C6 2.16 2.77 1.97
Control
Cl-GLUC 1060 2029 4761
C6-GLUC 622 1546 3922
C1/C6 1.7 1.3 1.2
Ratio of C1/C6 carbondioxide evolution. DPM/mg glomerul 
protein.
Time Adriamycin concentration
(hours) 0 0.5 l.OmM
0 3 +/- 0.23 4 +/“ 0-58 3 +/“ i-15
1 10 +/“ °-25 15 +/“ 1*15 18 +/“ i-15
2 12.5 +/- 0-15 18 +/“ 0.58 23 +/” 1-73
3 13.5 +/“ i*4 24 +/" °-58 34 +/" °-58
4 12.2 +/“ °-l7 43 +/" °-58 83 .+/" °-58
Figures represent % total LDH
175T
Effects of Adriamycin on LDH, ATP and Proline incoporation.
Adriamycin % Total LDH % Total ATP % control
Cone.urn 3H proline
0 18.8+/-0.58 100+/-6.1 100+/“10.4
15.6 70+/-0.52
31.3 18 +/“0.51 90.0+/-6.2 63+/"2.9
61.3 20 +/“ 0.56 87.7+/-4.0 49+/-1-73
125 21 +/-0.53 98.9 +/“ 7 -8 36 +/" 3 *46
250 22 +/- °-5 101.6 +/“ 2 31 +/“ 2.9
500 29 +/“ 0-58
1 7 6
Control values of LDH and ATP after 4 hours sonication.
LDH total Control ATP
392 11.6
299 6.5
411.4 4.1
338.3 9.2
Mean +/" SD 345.94 + / - 5 5 7.85 +/"
Figures represent LDH uirtol/min NADH utalised
ATP nmol/mg protien
.29
17 7
.FfciH LU b e  o j.iu .iiu  o u j-m u j.u u j_ u u i yjy r  a j. a t ju a  u
Cone. Cl-GLUC Cl-GLUC C1/C6
mM n
0 8 1885 +/“ 598 1204 +/” 558 1.56
0.125 3 3218 +/“ 1507 1051 +/“ 307 3.06
0.25 3 3946 +/“ 16^9 1540 +/" 1107 2.56
0.5 3 4887 +/- 1079 1070 +/“ 280 4 -57
GLUC = Glucose 
Cone = concentration
Mean DPM/mg glomeruli protein +/- standard deviation.
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